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Abstract
Pressure ulcers (PrU) are a secondary health complication that cause increased morbidity,
mortality and decreased quality of life. PrUs have also been shown to have a significant
financial burden on the healthcare system. Current best practice guidelines strongly
recommend the use of electrical stimulation (E-Stim) to increase healing rates of PrUs.
Unfortunately, there has been lack of uptake for the use of E-Stim in clinical practice. To
address this gap in practice, a knowledge mobilization project called the E-Stim
Collaboration Project was developed. The aim of this dissertation was to 1) determine if
an education program can change knowledge, attitudes and practice (KAP) in a variety of
health care providers providing care to people with PrUs, 2) the cost effectiveness of EStim, and 3) estimate the cost of PrU treatment in community dwelling individuals.
Chapter 2 outlines an education program that was developed for health care providers
(n=83) to determine whether KAP can be improved for the use of E-Stim in individuals
with chronic wounds. Knowledge and attitudes were found to be significantly increased
after the education program, certain attitudes changed after a hands-on workshop,
however practice change only occurred in 39% of participants. Chapter 3 evaluates the
cost effectiveness of E-Stim using decision analytic modelling to determine the cost per
quality-adjusted life year (QALY). The model results showed that E-Stim is a costeffective treatment for this patient population especially when compared to a more
commonly used advanced wound therapy called negative pressure wound therapy. In
Chapters 4 and 5, the cost of living in the community with a PrU is estimated from a
health care and societal perspective using current PrU treatment methods and showed an
average cost of $8247.48 per month which can be as high as $37,873.65 per month when
a person develops osteomyelitis in the bone underlying their PrU. Health care costs spent
to date on the 22 study participants who had their PrU for an average of 21.2 months was
approximately $3,846,624.50. Using advanced wound therapies such as E-Stim are
known to speed healing and avoid complications is warranted and cost effective.
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Thesis Introduction
The aim of this doctoral research is to improve wound care treatment for patients living
in the community with mobility impairment and pressure ulcers (PrU). A PrU is a
localized injury to the skin and/or underlying tissue usually over a bony prominence due
to pressure, or pressure in combination with shear. The severity and depth of PrUs has
been characterized by the National Pressure Ulcer Advisory Panel (NPUAP) using a
staging system of I-IV.1 Stage III and IV PrUs indicate a deeper wound. PrUs are a
prevalent secondary health complication for individuals with mobility impairment. In a
2004 Canadian prevalence study, it was reported that 26% of institutionalized patients
suffer with a PrU.2 In a Canadian Institute for Health Information (CIHI) report using the
discharge abstract database (DAD), a database which captures clinical information based
on physician hospital discharge summaries, the prevalence of PrUs in the community was
estimated to be 2.4%. This was assumed to be an underestimate due to lack of reporting.3
The cost of treating PrUs is also significant. A conservative estimate of annual costs for
wound care treatment in Ontario is $1.5 billion with PrUs and surgical wound infections
costing each Canadian hospital more than $1 million per year.4,5 Research has also
shown that hospital costs can range from $11,000 to as high as $90 000 for a single PrU.6
However, these costs are based on administrative databases which are known to be
flawed.
Multiple best practice guidelines have been developed to guide clinicians in the
management of PrUs. Best practice guidelines utilize a systematic approach to evaluate
treatment evidence and assist health care providers in making treatment decisions.
International, national, and local best practice guidelines for the treatment of PrUs have
made recommendations for the use of advanced therapies to speed the closure of PrUs.7–9
Advanced therapies is the term used for modalities that are utilized when standard
practices may not be adequate for wound healing.10 The advanced therapy which has the
highest level of evidence for the treatment of PrUs is electrical stimulation (E-Stim).11 EStim involves the placement of electrodes in or around a wound to deliver a small current
to the wound bed. By delivering this current to the wound, several wound healing
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processes are stimulated and optimized. Despite the vast amounts of evidence in the
literature supporting the use of E-Stim for PrU healing in multiple best practice
guidelines7-9 there has been lack of uptake for its use in hospitals, long term care or the
community.
To address the need for the implementation of E-Stim from “bench to bedside”, a
knowledge mobilization project called the E-Stim Collaboration Project was initiated.
Researchers collaborated with stakeholders from the hospital, long term care, and
community sectors to develop resources and pathways to increase the use of E-Stim as an
evidence-based intervention for PrU treatment. The aim of the E-Stim Collaboration
Project was to develop and sustain a comprehensive approach to delivering E-Stim that
could be replicated in different healthcare and community settings across Canada. As
part of this multi-year project, several facilitators and barriers were identified during the
first phase of the project.12 Two of the main themes identified as barriers for the uptake
of E-Stim included lack of knowledge and education, and concerns about expense (i.e.
cost of treatment). The focus of this thesis was to develop and evaluate an educational
framework for the implementation of E-Stim, and to analyze the costs associated with
living in the community with a PrU as part of the E-Stim Collaboration Project.
The E-Stim Collaboration Project used a model of care that was based on Knowledge to
Action (KTA) and National Implementation Research Network (NIRN) frameworks to
ensure the facilitation of knowledge translation into practice.12 This was completed using
plan, do, study act (PDSA) cycles to have an informed process for E-Stim
implementation. A total of five cycles were completed over a two year and nine month
time period. A detailed account of the E-Stim Collaboration Project and its use of
knowledge frameworks has been documented in the literature by Lala et al (2018).13

1.1 Educational Programs: Pressure Ulcer Prevention
A literature review was conducted to explore educational programs that have been
developed and evaluated for PrUs. Gunningberg in 2004 investigated the effect of a PrU
prevention program with 20- registered nurses (RNs) from hospital and community
settings in Uppsala, Sweden.14 Knowledge, as well as documentation and prevention
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strategies, were assessed immediately before and after an educational program, as well as
eight months after attending the educational program. Knowledge was measured using a
questionnaire and documentation was evaluated by conducting chart reviews. PrU
prevention strategies used by nurses were assessed by interviewing the head nurse before
and eight months after the education program to determine nursing change in practice.
The educational program delivered by Gunningberg consisted of a multidisciplinary team
approach and included 40 hours of lecture and 40 hours of practice. The authors found a
significant increase in knowledge about PrU prevention after the educational program.
At eight-month follow-up, 55% of the RNs had implemented new routines based on the
education they received. Documentation on patient risks and treatment interventions for
the prevention of PrUs was still lacking after the program.
Sinclair et al, 2004 assessed the difference in knowledge between RNs and licensed
practical nurses (LPNs) immediately after and three months following a PrU prevention
workshop.15 Five hundred, ninety-five RNs and 59LPNs who worked at one of three
hospitals in Calgary, Alberta, Canada participated in the study. The researchers assessed
change in knowledge using a modified version of the Pressure Ulcer Knowledge
Assessment Tool (PUKAT) which included 53items on PrU staging, wound description
and risk assessment and prevention.16 Knowledge was significantly higher after
attending the 3.5hr workshop compared to pre-workshop scores. There was a decrease in
knowledge in the three months follow up scores in relation to the scores immediately
after the workshop. The authors concluded that the education for evidence-based practice
in PrU prevention is effective and suggested that ongoing staff education for PrU
prevention and treatment is both necessary and important.
Results from prior studies support the need for educational programs to increase
knowledge for PrU prevention, however, an increase in knowledge does not always lead
to a change in practice.14,15 In order to further evaluate comprehension of PrU
prevention, knowledge, attitude, and practice (KAP) surveys have been utilized to assess
individual’s behaviour. KAP surveys identify what people know (knowledge), how they
feel (attitude) and what they do (practice).17 Kallman and Suserud (2009) used a
questionnaire consisting of 47 items designed to assess RNs and nursing assistants (NAs)
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knowledge, attitudes and practices as well as perceived possibilities and barriers
regarding PrU prevention.18 Two hundred and thirty questionnaires were distributed in
both community and hospital care settings in the western part of Sweden. Sixty-seven
percent of participants responded, and the authors found that nursing staff had a positive
attitude regarding PrU prevention. They reported that nurses had a generally good
knowledge about prevention and the treatment of pressure injuries, although in terms of
practice only 37% (n=55) of the participants said that they have a strategy in place for
PrU prevention at their place of work. The authors concluded that given the low number
of reported PrU prevention strategies, this may adversely affect the quality of care
provided to the patients and lead to PrU development.
Strand and Lindgren in 2010, distributed a questionnaire to assess nurses knowledge,
attitudes and perceived barriers and opportunities towards PrU prevention in an intensive
care unit (ICU) setting in a Swedish hospital.19 A total of 315 questionnaires were
distributed and 146(46%) were completed and returned for evaluation. PrU staging was
correctly made by only 47% of respondents and the authors noted that several
respondents did not answer some of the knowledge questions. Perceived barriers to PrU
prevention included lack of time for interventions such as turning schedules, and severely
ill patients in the ICU setting. Opportunities for knowledge and access to pressure
relieving equipment were most commonly reported as facilitators for best practices. The
authors concluded that raising knowledge among nursing staff as well as making PrU
prevention a priority in daily care is an important organizational challenge in the ICU.
Demarre et al(2011) completed a cross-sectional multi-centre study to evaluate the
association between knowledge and attitudes of nurses and nursing assistants, and
compliance with PrU prevention guidelines in residents at long term care homes in
Belgium.20 PrU prevention was defined as fully compliant if all preventative measures in
bed and when seated were applied, partly compliant if some measures were applied in
bed and/or while seated, and no prevention compliance if there was a total absence of any
adequate preventative measure. Knowledge and attitude was assessed using a random
sample of at least five nurses from 18 participating long-term care wards. The PUKAT
and Attitude towards Pressure Ulcers (APuP) instrument were used, both of which have
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been validated in the literature.16,21 One hundred and forty-five nurses and nursing
assistants were included, and compliance with the guidelines was evaluated in
615residents. The mean knowledge scores were 29% for nurses and 29% for nursing
assistants. The overall attitude score was 75%. The authors concluded that attitudes of
nurses and nursing assistants towards pressure injuries were strongly associated with the
application of fully compliant PrU prevention guidelines, while knowledge was not.
Cullen-Gill et al in 2013 also used the PUKAT and APuP instruments to evaluate the
knowledge and attitudes of fourth-year undergraduate nurses towards PrU prevention.22
A quantitative cross-sectional survey design of 60 undergraduate nurses revealed that
nursing students had an overall positive attitude towards PrU prevention, but a poor
knowledge of PrU prevention methods. Simonetti et al(2015) assessed a total of 742
nursing student’s knowledge and attitudes on PrU prevention using the PUKAT and
APuP in seven Italian nursing schools.23 The overall knowledge scores were 51% and
attitude scores were 77%. The authors found a weak correlation between total knowledge
scores and total attitude scores and concluded that their results suggested that positive
attitudes toward PrU prevention may contribute to the compliance with clinical practice
guidelines in PrU prevention.
Review of the existing literature revealed that PrU prevention educational programs have
been well studied; however, there are gaps in terms of PrU treatment educational
programs. Research also suggests there may be a disconnect between having the
knowledge about what to do and implementing that new knowledge into practice. Based
on the findings of the literature review, an educational framework was developed and
delivered as part of the E-Stim Collaboration Project and knowledge, attitudes, and
practice were measured before and after completing the educational program (see
Chapter 2).

1.2 Cost of Pressure Ulcers
To be successful in the implementation of an advanced therapy in the current healthcare
climate, knowledge of its use and effectiveness is not enough to influence a change in
practice. Costs associated with treatments and how one advanced therapy may be more
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cost effective than a comparator is an important factor to influence change. Treatment
effectiveness as well as cost benefit through cost analysis is required to engage health
care providers, stakeholders and decision makers.
To address the question of costs associated with interventions for the treatment of PrUs, a
literature search was conducted for economic analysis evaluations that have been
completed on interventions to speed the healing of PrUs. Three systematic reviews were
found that have synthesized information on the cost-effectiveness for the treatment of
PrUs.24–26 Tricco et al(2015) sought to elucidate cost-effective treatment strategies for
all types of complex wounds.24 Fifty-nine cost-effectiveness studies were included in the
systematic review, with 14 of the included studies evaluating interventions for the
treatment of PrUs.27-40 Of the 14 included studies, 10 evaluated the cost effectiveness of
PrU dressings 28-30,32,34-38,41, one evaluated the cost effectiveness of growth factors in PrU
healing31, one evaluated the cost-effectiveness of a specialized nursing intervention
program on the healing of PrUs39, and two evaluated the cost effectiveness of pressure
management surfaces on the treatment of PrUs.27,33 Of these included studies, three
interventions were found to be dominant (more effective and less costly)for the treatment
of PrUs. The dominant treatments included moisture vapor permeable dressing vs.
gauze, advanced dressings vs. gauze, and hydrocolloid vs. gauze.
In 2014 Carter conducted a systematic review of literature that addressed the economic
evaluation of guideline-based or strategic interventions for the prevention or treatment of
chronic wounds and identified two studies that assessed the cost effectiveness of PrU
management.26 The first study evaluated the cost effectiveness of a PrU dressing41 and
the second evaluated the cost effectiveness of an incentive strategy for the treatment of
PrUs.43 Palfreyman and Stone(2014) completed a systematic review of economic
evaluations assessing interventions aimed at preventing or treating PrUs. They found 23
studies for inclusion in the analysis, 11 of which were specific for PrU
treatment.33,35,36,38,41,42,44-48 Eight studies evaluated the cost effectiveness of dressings on
PrU management35,36,38,42,45,46,48, two evaluated the cost effectiveness of pressure
managing surfaces for the treatment of PrUs33,44, and one study evaluated the cost
effectiveness of E-Stim for the treatment of PrUs.47 The majority of the studies had ulcer
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healing as the primary outcome measure but one used rate of healing.36 Conclusions
from both systematic reviews were similar reporting that there is a plethora of evidence
based best practice guidelines for the treatment of PrUs, however evidence of costeffectiveness for various interventions is lacking.
In review of the literature, only one cost-effectiveness study for the evaluation of E-Stim
for the treatment of PrUs was identified. The study by Mittmann et al, 2011 evaluated
the incremental cost-effectiveness of E-Stim plus standard wound care (SWC) versus
SWC alone in a spinal cord ulcer population with stage III/IV PrUs in Ontario, Canada
from the public payer perspective.47 A decision analytic model was constructed for a
one-year time horizon. Model inputs for the clinical probabilities and direct health
system and medical resources were based on a randomized controlled trial of E-Stim plus
SWC versus SWC alone.49 They found that E-Stim plus SWC were associated with
better outcomes and lower costs than SWC alone. There was a 16.4% increase in the
PrUs healed and a cost saving of $224 at one year. Therefore, E-Stim plus SWC was
considered a dominant strategy. Despite this evaluation, E-Stim continues to be
underutilized as an advanced therapy for PrU treatment.
This thesis will focus on the education and cost aspects of the E-Stim Collaboration
Project, a large, multi-sector knowledge mobilization project conducted in the South
West Local Health Integration Network (LHIN). Chapter 2 reports on the evaluation of
the educational program developed for health care providers to address the gap of
knowledge and awareness for the use of E-Stim for PrU treatment. Chapter 3 is a cost
analysis using modelling to compare the advanced therapy of E-Stim to another
commonly used advanced therapy; negative pressure wound therapy (NPWT). Chapter 4
estimates the costs of living in the community with a mobility impairment and PrU to
establish baseline data prior to intervention. Chapter 5 is a case study estimating the cost
of an individual with an SCI and PrU with underlying osteomyelitis.
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2

Evaluation of an Education Program for the use of Electrical
Stimulation Therapy to Heal Pressure Ulcers
2.1 Introduction
Pressure ulcers (PrU) are a common complication occurring across all sectors of health
care including hospitals, long term care, and home and community care.1,2 PrUs result in
a decreased quality of life3–5 and increased mortality rates.6–8 PrUs also cause a large
financial burden to the health care system. It has been estimated that PrU care can have a
monthly cost of $4,750 CDN for individuals with a spinal cord injury who live in the
community, and the hospital cost of a single PrU can range from $11,000 to $90,000
CAN.9–11 Given the high cost to patients and the health care system, it is imperative that
evidence-based interventions are utilized to maximize healing rates in patients with a
PrU.
Electrical stimulation (E-Stim) involves applying low levels of electrical current in or
around a wound for the purpose of promoting wound closure.12–15 E-Stim is strongly
recommended for the treatment of PrUs and had the highest level of evidence (level 1a)16
in several national and international best practice guidelines.17–20 Despite having the
highest level of evidence, there has been little uptake for the use of E-Stim in clinical
practice. One of the perceived barriers to the implementation of E-Stim is the lack of
competency in providing the treatment in the community which is associated with the
lack of awareness of E-Stim, lack of knowledge, and lack of training and skill.21
Educational programs about PrU prevention have been well studied; however, there is
limited information about implementation of treatment programs for PrUs. To date, the
impact of educational programs on knowledge, attitudes and practices (KAP) of
practitioners have focused on the nursing profession and implementing practices that
address pressure ulcer prevention. Additionally, previous studies have evaluated change
in knowledge over time, but none of the studies measuring KAP reassessed the effect that
an educational intervention had on these attributes.22–28
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Gunningberg (2004) and Sinclair et al (2004) investigated the effects of a PrU prevention
educational program with nurses. Both studies found a significant increase in nurse’s
knowledge immediately after the educational programs, however the knowledge gained
was not sustained when re-evaluated several months later.22,23 These findings suggest
that education on PrU prevention is effective but requires ongoing staff education to
ensure continued knowledge. Research has also shown that an increase in knowledge
does not always lead to a change in practice. To further evaluate comprehension of PrU
prevention, KAP surveys have been developed. KAP surveys identify what people know
(knowledge), how they feel (attitude) and what they do (practice).29 Kallman and
Suserud(2009) used a KAP survey and found that nursing staff as a whole had a positive
attitude and good knowledge about prevention and the treatment of PrUs; however,
results relating to practice were poorer.24 They concluded that without a change in
practice, the quality of care provided to patients may be adversely affected and lead to
PrU development.
Strand and Lindgren in 2010 used a questionnaire to assess nurses knowledge, attitudes
and perceived barriers and opportunities towards PrU prevention. They found
educational opportunities and access to pressure relieving equipment were most
commonly reported as ways to improve PrU prevention.27 Demarre et al(2011) examined
the correlation between the knowledge and attitudes of a random sample of RNs and
nursing assistants (NAs) working in long term care homes.30 Knowledge and attitudes
were measured using the previously validated Pressure Ulcer Knowledge Assessment
Tool (PUKAT) and the Attitude towards Pressure Ulcers (APuP) instruments.31,32 The
mean knowledge scores for RNs and NAs were relatively low (less than 30%) while
attitude scores were high (74.5%). The authors concluded that attitudes of RNs and NAs
towards PrUs were significantly correlated with the application of PrU prevention
guidelines, while knowledge was not. Collectively these studies suggest that positive
attitudes toward PrU prevention may contribute to compliance with clinical practice
guidelines in PrU prevention more than knowledge scores.

16

The purpose of this study was to determine if an educational program can change KAP in
a variety of health care providers providing care to people with PrUs living at home.
Specifically, we set out to identify:
a)
b)
c)
d)

Negative attitudes for the use of E-Stim which may impact its clinical use;
The outcome of an online educational program on knowledge and attitudes;
The outcome of a hands-on workshop on knowledge and attitudes; and
If participation in an educational program can translate to a change in practice.

2.2 Setting
The educational program described in this article was developed as part of a multi-year
knowledge mobilization project aimed to implement E-Stim for treating pressure injuries
in community dwelling individuals with spinal cord injury (SCI) living in one region of
Ontario, Canada. Within this region, health care is coordinated by the South West Local
Health Integrated Network (South West LHIN) which is funded by the Ministry of Health
and Long-Term Care. The South West LHIN provides home care services by
contracting several provider agencies that employ nurses, allied health professionals, as
well as unregulated support workers. The overall aim of the E-Stim Collaboration
Project was to support home care services of the South West LHIN in a way that
promoted uptake and use of E-Stim therapy in a sustainable way. This portion of the
project will focus on how we addressed the lack of information and training about E-Stim
that was identified as a barrier during a pre-implementation environmental scan.21

2.3 Methods
The quasi experimental design involved healthcare providers from different disciplines
who volunteered to participate in the educational program. Participants’ knowledge and
attitude was measured at three points: 1) Pre-Education, 2) Post-Online and 3) PostWorkshop. Participants’ change in practice was assessed six months after receiving the
hands-on education.
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2.3.1 Subjects
As part of the E-Stim Collaboration Project, an awareness campaign was conducted to
engage providers in all healthcare sectors including the community, homecare, long term
care, hospitals and private clinics in the South West LHIN. Multiple agencies with a
variety of healthcare providers were visited by a research team member who provided
information about the E-Stim Collaboration Project and invited them to participate in the
E-Stim Education Program. Participation in the education program was not limited to
healthcare providers within the South West LHIN. The South West LHIN home and
community care (HCC) providers had access to E-Stim equipment and supplies through
previously established vendor contracts.
All the participants who took part in the educational program signed written consent after
reading a letter of information. The study was approved by the ethics review committee
of Western University Health Science Research Ethics Board of London, Ontario,
Canada (HSREB File Number 107778, Appendix 1). Informed written consent was
obtained from all participants to share pooled results of completed tests and surveys
(Appendix 2). Before beginning the education, demographic information was collected
about the participants professional background, education and experience in providing
wound care (see Table 1).
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Table 1: Participant Demographic Data (n=74)
Profession
Registered Nurse
Physiotherapist
Enterostomal Therapist
Occupational Therapist
Registered Nurse Practitioner

N
32
20
8
6
5

%
43
27
11
8
7

Province
Ontario
Alberta
Newfoundland
Nova Scotia
Percent of role in wound care

N
70
2
1
1

%
95
3
1
1

Other
Physician
Experience, year
0-5
5-10
10-15
More than 15
Sector
Hospital
Home Care
Clinic
Long Term Care
More than one of above
Role in Wound Care

2
1

3
1

21
16
6
30

28
22
8
41

33
22
9
8
1

45
30
12
11
1

41
16
5
4
8

55
22
7
5
11

58
14
1
1

78
19
1
1

19
23
9

26
31
12

Direct
Indirect
Organizational Support
None of the above

50
15
4
4

70
20
5
5

< 25
25-49
50-74
75-99
100
Work Hours
Full time
Part time
Casual
Other
Level of Wound Education
In-services
1-2-day workshops
Enterostomal Therapy
Certificate
Certificate Program
Master’s level
Other

7
7
9

9
9
12

2.3.2 Education Program
An education program for the use of E-Stim on PrUs was developed to address key
competencies for skilled application. The education program was delivered in two
phases: online modules and a hands-on workshop. The educational program was
developed based on prior consultation with key stakeholders who identified perceived
facilitators and barriers of implementing E-Stim for PrU healing.21 Many stakeholders
stated that there was lack of awareness, knowledge, training, and skills surrounding the
use of E-Stim. The stakeholders expressed a preference for open educational resources
that would be freely accessible online and available in print, in addition to hands-on
demonstrations on how to use E-Stim.21
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2.3.3 Online Modules
The modules were completed using a secure online learning platform associated with
Western University and were developed to allow participants to review material at their
own pace and on their own schedule. Online learning allowed for increased access for
participants, and modules could be reviewed as needed. The online modules consisted of
background theory and knowledge using narrated PowerPoint presentations that were
organized into eight recorded lectures totaling approximately four hours. See Table 2 for
a description of the content contained in the eight modules.
Table 2: Online Module Descriptions
Module
Number
1.

2.
3.
4.
5.
6.
7.
8.

Summary
Overview of the course content and pre-requisite information including
wound healing principles, best practice guidelines, wound bed preparation,
wound assessment and aseptic technique.
The history of E-Stim, basic overview of what E-Stim is, and different types of
equipment for E-Stim delivery.
Review of the biological mechanisms and physiological processes that speed
the healing process with the use of E-Stim.
Clinical research evidence and clinical practice guidelines for the use of EStim.
Indications, precautions and contraindications for the use of E-Stim in
pressure injuries.
Overview of dressings that are compatible for use with E-Stim in pressure
injuries.
Electrical Principles and stimulus parameters
A detailed review of application techniques. Including three 5-7minute
videos that showed different ways to deliver electrical currents to the wound
and peri-ulcer skin. These demonstrations allowed participants to see how to
apply E-Stim during the workshop as well as later when they needed
reminders.

2.3.4 Hands-on Workshop
Once participants completed the online modules, they were invited to participate in one
of seven hands-on workshops that were offered over a one-year period in different
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locations. The hands-on workshop began with a brief overview of the content from the
online modules. The main objective for the hands-on workshop was to develop the
clinical skills required to apply E-Stim to patients with PrUs and included interactive case
discussions to promote critical thinking and the clinical decision-making judgements
necessary to use E-Stim in a safe and effective manner.
The specialized equipment and supplies (electrodes, leads) required for the delivery of EStim to wounds was available during the hands-on workshop. The first component of
the workshop was initiated with a demonstration of E-Stim application techniques.
Wound healing fundamentals including wound bed preparation, wound etiology, and
aseptic techniques were embedded throughout the hands-on session.17-20 Participants
were able to actively set up the E-Stim equipment on realistic latex wound models. They
also were encouraged to experience the sensation of E-Stim to diminish fears and
describe expected sensations to their patients. This was followed by a peer evaluation
that was supervised by two of the study researchers to confirm participants completed all
the application steps in a safe and effective manner.
The second component of the workshop included a review of wound dressings that are
compatible with E-Stim. Participants were exposed to samples of different types of
wound dressings and products. Selection and rationale of the most appropriate dressing
for each case was developed via interactive case discussions with the class. Patient
scenarios were developed and reviewed during the hands-on workshop to test
participant’s understanding of electrical principles and how changing the E-Stim set up or
wound environment can affect electrical current flow.
At the end of the workshop, the clinicians were invited to participate in a Community of
Practice which continued to meet monthly to share experiences and discuss challenges
regarding E-Stim implementation via a secure web-based online video/audio link. The
community of practice was developed as part of the E-Stim Collaboration Project and
provided an online forum to link over 300 clinicians across Canada who are working in
this field.
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2.4 Instruments
2.4.1 Knowledge Test
Knowledge about principles of electricity, mechanism of action, and research evidence
was measured using a multiple-choice test. The knowledge test was either administered
online where 10 questions were randomly selected from a pool of 25 multiple choice
questions, or on paper where all 25 questions were included in an in-class quiz (PostWorkshop). Knowledge questions were developed by the research team and pilot tested
during a pre-study education session.

2.4.2 E-Stim Attitude Survey (EAS)
An attitude survey was developed by the research team to understand the attitudes
participants had towards the use of E-Stim on pressure injuries and their willingness to
incorporate an advanced therapy into practice (Table 3). The survey was based on the
APuP test developed by Beeckman et al, 2010.30
Questions were grouped into three subscales to define participant’s attitude including:
1. Education: Attitude towards the importance of knowledge and skills for the use of EStim in practice.
2. Evidence based practice: Attitude towards research evidence and effectiveness of EStim to stimulate/accelerate the healing of pressure injuries
3. Resources: Attitude towards efficiency and equipment needs when using E-Stim in
clinical practice
The EAS consisted of 14 items measured on a 5-point Likert scale including Strongly
Agree, Agree, Neutral, Disagree and Strongly Disagree. The education subscale
consisted of 5 items, the evidence-based practice subscale consisted of 4 items, and the
resources subscale consisted of 5 items. Internal consistency measured using
Cronbach’s alpha was calculated for each subscale and found to be acceptable for
education (α=0.74), evidence-based practice (α=0.76), and resources ( α=0.74).
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Table 3: E-Stim Attitude Survey (EAS)
EDUCATION SUBSCALE
1. Based on my current knowledge, I am willing to incorporate E-Stim into my current practice.
2. I am reluctant to use E-Stim because of the high risk of harm to my patients.
3. I cannot use E-Stim because it is not within my scope of practice.
4. I do not feel I have the advanced knowledge and skills that are required to apply E-Stim to wounds.
5. I need more hands-on practice and clinical experience with E-Stim before I could use it in my clinical
practice.

EVIDENCE BASED PRACTICE SUBSCALE
6. Providing E-Stim to patients with delayed wound healing is important.
7. The individuals I see with open wounds are more appropriate for negative pressure wound therapy
rather than E-Stim.
8. The individuals I see with open wounds could benefit from E-Stim.
9. There is little evidence to support the use of E-Stim for individuals with pressure injuries.

RESOURCES SUBSCALE
10. I currently use E-Stim when appropriate for individuals with stalled or non-healing wounds.
11. I don’t have time to provide E-Stim treatment to my clients.
12. I have good support from supervisors and managers to use E-Stim in my clinical practice.
13. The cost to provide E-Stim to patients is too high.
14. The equipment required to use E-Stim is not available to me.
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2.4.3 Practice Change
To assess change in practice, participants were followed up via email six months PostWorkshop session and asked the following question:
Since attending the E-Stim Consultant Education, I have used E-Stim for chronic
would healing on: a) 1-5 patients; b) 6 or more patients; or c) I have not used E-Stim
since attending the workshop.

2.5 Time Course of Evaluations
Knowledge tests and the EAS survey were evaluated at three time points throughout this
study; prior to commencing the education (Pre-Education), after completing the online
modules (Post-Online), and after completing the hands-on workshop (Post-Workshop).
Tests and surveys were administered electronically via the online education system Preeducation and Post-Online. A paper tool was used to evaluate the participant’s
knowledge and attitudes Post-Workshop.

2.6 Data Analysis
Eighty-seven individuals completed both the online modules and the hands-on workshop.
Of the 87 who completed the education program, 83 individuals were included for data
analysis. Four participants were excluded due to missing baseline data.

Demographic

information describing the type and amount of clinical experience were collated and
analyzed using descriptive statistics. See Table 1.
Knowledge was assessed using the percentage of correct answers on the knowledge test.
EAS results were converted to numeric scores to analyze the data. Attitudes were
assessed using the subscales of education, evidence-based practice, and resources. To
evaluate the impact of the education program on knowledge, and on the three subscales
of the attitude questionnaire, a separate linear mixed effects model was fit to each of the
four dependent variables. Time of measurement (Pre-Education, Post-Online, PostWorkshop) was included in the model as a fixed effect, and participants were included as
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a random effect. Utilizing a linear mixed effects model allowed us to use all available
data without the need for list-wise deletion of participants with missing data, or
interpolation of these missing data points.32 The statistical significance of the fixed
effect was identified by comparing this model to a ‘null’ model in which the dependent
variable was predicted only by random error. In the event of a statistically significant
fixed effect, post-hoc testing was done by testing all possible pairwise comparisons using
t-tests with degrees of freedom estimates that were calculated using a Satterthwaite
approximation. All statistical analyses were performed in R33, with linear mixed effects
analyses conducted using the lme434 and lmerTest35 packages. Post-hoc pairwise
comparisons were completed using the lsmeans package.36

2.7 Results
2.7.1 Demographics
The majority of the participants were registered nurses (43.2%) followed by
physiotherapists (27.0%), enterostomal therapists (10.8%), occupational therapists
(8.1%), registered practical nurses (6.8%), other (2.7%) and one physician (1.4%). Most
participants worked in a hospital environment (55.4%) and in a full-time capacity
(78.4%). Participants had a variety of background knowledge in wound management but
the majority (56.8%) had taken either in-services or 1-2-day workshops as their highest
level of wound care knowledge.

2.7.2 Change in Knowledge Scores
Mean scores for the knowledge tests for the three time points are presented in Figure 1.
Total scores ranged from 20-100% Pre-Education, 50-100% Post-Online and 52-96%
Post-Workshop. Using the mixed effects model, the effect of time was statistically
significant (p < .001). Post-hoc evaluation showed that there was a statistically
significant increase in knowledge from Pre-Education to Post-Online, t (145) = 9.18, p <
.0001. Knowledge scores were higher Post-Workshop compared to Pre-Education, t
(141) = 9.81, p < .0001. Participants were most challenged by E-Stim knowledge
questions pertaining to biological mechanisms and the physiological effects of E-Stim.
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Knowledge Scores (N=83)
100
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80
70
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Evaluation Time Point

Figure 1: Knowledge Test Scores;

= significant difference

2.7.3 Change in Attitude Scores
Baseline attitude scores for the EAS are shown in Figure 2. Mean scores for the EAS
subscales of education, evidence-based practice, and resources over time are shown in
Figure 3. Post-hoc analysis revealed that there was a significant increase in attitudes
related to the education subscale over all three time points: Pre-Education and PostOnline, t(140)=7.08, p < .05; Pre-education and Post-Workshop, t (136) = 10.98, p < .05;
and between Post-Online and Post-Workshop surveys, t (140) = 3.13, p < .05.
For the evidence-based practice subscale, attitudes were significantly increased between
Pre-Education and Post-Online groups, t (127) = 6.03, p < .05, as well as between Pre-
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Education and Post-Workshop, t (122) = 4.86, p < .05, but not between Post-Online and
Post-Workshop.
For the resources subscale, there was also a significant increase in attitudes between PreEducation and Post-Workshop, t (113) = 5.22, p < .05, Post-Online and Post-Workshop, t
(115) = 4.07, p < .05, but not between Pre-Education and Post-Online time points.
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Attitude Scores Pre-Education (N=83)
RESOURCES SUBSCALE
The equipment required to use E-Stim is not available to me.
The cost to provide E-Stim to patients is too high.
I have good support from supervisors and managers to use EStim in my clinical practice.
I don’t have time to provide E-Stim treatment to my clients.
I currently use E-Stim when appropriate for individuals with
stalled or non-healing wounds.
EVIDENCED BASED PRACTICE SUBSCALE
There is little evidence to support the use of E-Stim for
individuals with pressure injuries.
The individuals I see with open wounds could benefit from EStim.
The individuals I see with open wounds are more appropriate
for negative pressure wound therapy rather than E-Stim.
Providing E-Stim to patients with delayed wound healing is
important.
EDUCATION SUBSCALE
I need more hands-on practice and clinical experience with EStim before I could use it in my clinical practice.
I do not feel I have the advanced knowledge and skills that are
required to apply E-Stim to wounds.
I cannot use E-Stim because it is not within my scope of
practice.
I am reluctant to use E-Stim because of the high risk of harm to
my patients.
Based on my current knowledge, I am willing to incorporate EStim into my current practice.

0
Strongly Agree/Agree
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Figure 2: E-Stim Attitude Survey Pre-Education Program
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Change in Attitudes over Time (N=83)
5
4.5
4
3.5

Score

3
2.5
2
1.5
1
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Attitude Subcategory Evaluation
Pre-Education

Post-Online

Figure 3: E-Stim Attitude Survey Scores;
Education Scores,

Post-Workshop

= significant difference from Pre-

= significant difference from Post-Online

2.7.4 Practice Change
Thirty-three of a potential 83 participants who had completed the hands-on session six
months prior responded to the practice change question (40% response rate). Of the
group that responded, 33% had used E-Stim on 1-5 patients, 6% had used E-Stim on 6 or
more patients, and 61% had not used E-Stim since attending the workshop.

2.8 Discussion
The results of this study have demonstrated that a customized online education program
increased knowledge about E-Stim in a group of multidisciplinary health care providers.
Subsequent completion of a hands-on workshop was required to change certain attitudes
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about E-Stim. Despite being able to increase knowledge and improve attitudes toward EStim, less than half of the responding participants changed their practice six months after
attending the education program.
To our knowledge, this is the first research study to evaluate the knowledge, attitudes and
practices regarding the use of E-Stim by health care providers involved in the treatment
of PrUs. Assessment of knowledge and attitudes for the use of an evidence-based
intervention such as E-Stim is important given the many barriers associated with the
implementation of evidence-based guidelines.21 Our study showed that a 4-hour online
education program could significantly improve clinician’s knowledge about E-Stim.
Clinicians could independently complete this online program when it was convenient,
and this background information could be referenced in the future when required by the
clinician.
Interestingly, there was no further increase in knowledge detected after completion of a
hands-on session. This was expected given the theoretical knowledge component of the
educational program was delivered via online modules and we did not repeat any of the
background knowledge during the hands-on workshop. It is also possible that we were
unable to detect changes in knowledge scores after the hands-on workshop because the
test was administered differently pre and post workshop. The paper-based test with all 25
multiple choice questions that was administered after the workshop may have been more
difficult than previous tests where only 10 questions were selected randomly.
The EAS was used to assess whether clinicians would be more willing to incorporate EStim as PrU treatment. The education subscale, which measured attitudes about the
importance of E-Stim knowledge, increased after the online education and continued to
improve after the hands-on workshop. This demonstrates that attitudes towards the
importance of E-Stim knowledge can be optimized when a combination of online and
face to face skills workshop are provided. In evaluating the attitude pre-education scores,
69 (83%) participants agreed with the statement “I need more hands-on practice and
clinical experience with E-Stim before I could use it in my clinical practice.” Fifty-two
participants (63%) also agreed with the statement “I do not feel I have the advanced
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knowledge and skills that are required to apply E-Stim to wounds”. We were able to
demonstrate a significant increase in attitudes towards the use of E-Stim after our
education program, however a hands-on workshop was not sufficient to change
clinician’s practices. Further mentorship and education in a clinical setting may be
required to increase use of E-Stim for PrU treatment.
The evidence-based practice subscale, which measured attitudes towards research
evidence and E-Stim effectiveness, increased after completing the online modules but did
not change after the hands-on workshop. The lack of change in this portion of the
attitude survey is likely because information about clinical research and best practice
recommendations was only included in the online modules, and not part of the hands-on
workshop. The resources subscale measured attitudes towards E-Stim efficiency and
equipment needs and showed that improvements in this attitude did not occur until after
completing the hands-on workshop. This is because we provided in the hands-on
workshop an opportunity for participants to observe and use the specialized equipment
and supplies that were available to them for E-Stim treatments.
Previous studies have shown an increase in nurse’s knowledge after educational
workshops, but did not evaluate attitudes.22,23 The studies that evaluated attitudes, did not
assess if an educational program could change nurses attitudes.24,25,27,28,35 Our findings
demonstrate the importance of providing a combination of knowledge and skills, and
having a hands-on workshop. We were able to overcome these negative attitudes and
barriers to E-Stim implementation by having the equipment available for participants to
use during the workshop and have a better understanding of the time and steps required
for E-Stim set up. We also required all course participants to demonstrate they were able
to manipulate the equipment and set up all the supplies appropriately during the hands-on
workshop.
Although we found that knowledge and attitudes towards E-Stim improved significantly
after this education program, only 39% of respondents had used E-Stim in their wound
care practice six months Post-Workshop. This relatively low rate of practice change is
consistent with other reports that showed improved knowledge does not subsequently

31

impact behavior.36 Of the 83 participants, only 33 responded. With this response rate
(40.8%) it is unclear whether this relatively low level of E-Stim use is representative of
the larger group of clinicians who completed the education. It is possible this rate of
practice change may be falsely elevated given that participants who used the intervention
may be more willing to respond to the question. We did not investigate the reasons why
participants did not use E-Stim in their practice. It is possible that they did not receive
referrals or encounter appropriate patients for E-Stim treatment.
A lack of translation of knowledge into practice is not uncommon.37–39 Beeckman et al
in 2011 evaluated the relationship between knowledge, attitudes and the application of
evidence-informed PrU prevention strategies for nurses working at 14 Belgian hospitals.
They concluded that nurse’s knowledge about PrU prevention was inadequate and that
knowledge of prevention methods was not associated with the application of prevention
methods. Attitude scores were higher than the knowledge scores and did have a
significant correlation with evidence-based practices being utilized for patients.
Previous studies that recorded nurse’s attitudes toward evidence-based practices in PrU
prevention showed nurses were negatively affected by a lack of resources; more
specifically lack of time40, lack of nursing staff40,41 and insufficient equipment.41 In our
study, we know that the equipment and processes needed to provide this E-Stim to
patients living in this region were in place over this time period.
The challenge with producing practice change and encouraging clinicians to adopt new
approaches into clinical care is well documented in the literature.36, 42–45 This has fueled
the emergence of a new area of research called implementation science. Despite
numerous frameworks and established processes to identify and address barriers and
involve end users, sustained practice change remains elusive. Our experience suggests
that filling knowledge gaps and addressing concerns about competency using an
innovative and very accessible education program is only part of the underlying problem
with getting new treatments into wound care practice.
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2.9 Conclusions
Training is perceived as a barrier for the implementation of evidence-based practice in
wound healing, specifically for the use of E-Stim in the treatment of pressure injuries.
Education delivered using online modules that includes theoretical background and a
critical review of clinical research evidence can increase health care providers
knowledge about E-Stim and other best practices used in the treatment of PrUs. A oneday face to face session which involved practice with hands-on skills was required to
improve certain attitudes towards E-Stim. More clinicians who completed this education
used E-Stim in their practice; however, the rate of practice change remained low. These
findings suggest that further intervention is required to change practice patterns, such as
ongoing coaching and mentorship in the clinical setting.
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3

Evaluation of the Cost-Effectiveness of Electrical Stimulation
and Negative Pressure Wound Therapy versus Standard
Wound Care for the Treatment of Pressure Ulcers
3.1 Introduction
Pressure ulcers (PrU) are a common and costly complication occurring across all sectors
of health care. In 2013, the Canadian Institute for Health Information (CIHI) reported
PrU prevalence rates that ranged from 0.4 percent to 14.1 percent in acute care, home
care, long term care and complex continuing care.1 It has been estimated that PrU care
can have a monthly cost of $4,750 CDN for individuals with a spinal cord injury who live
in the community and the cost of a single PrU can range from $11,000 to 90,000 CAN.2-4
The severity and depth of PrUs has been characterized by the National Pressure Ulcer
Advisory Panel (NPUAP) using a staging system between I-IV.5 Stage III and IV PrU
indicate a deeper wound. Given the high cost to patients and the health care system, it is
imperative that evidence-based interventions are utilized to maximize healing rates in
patients with a PrU. Multiple best practice guidelines have been developed nationally
and internationally to guide clinicians to implement best practices for the treatment of
PrU.6–8 Interventions for the management of PrUs include pressure offloading,
appropriate nutrition, pain management, and local wound care which can include the use
of advanced therapies such as electrical stimulation (E-Stim) or Negative Pressure
Wound Therapy (NPWT).
E-Stim involves the delivery of low-level current via surface electrodes to the area of the
wound bed for speeding wound closure. Several randomized controlled trials, systematic
reviews and meta-analyses have concluded that E-Stim can speed healing and promote
wound closure.9 Despite having strong recommendations to use E-Stim in several best
practice guidelines, there has been little uptake of the use of E-Stim in clinical practice
for the treatment of PrUs.6 This may be due to implementation barriers including: lack of
interdisciplinary collaboration and communication amongst providers between and across
settings, inadequate training, and lack of resources such as funding, time, and staff.10 To
address these barriers, a multi-year research project was conducted in community
dwelling individuals living in one region of Ontario, Canada. Within this region health
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care is coordinated by the South West Local Health Integrated Network (South West
LHIN) that is funded by the Ministry of Health and Long-Term Care (MOHLTC). The
South West LHIN provides home care services by contracting several provider agencies
that employ nurses, allied health professionals, as well as unregulated support workers.
The E-Stim Collaboration Project was a knowledge mobilization project with the overall
aim to support home care services of the LHIN in a way that promoted uptake and use of
E-Stim therapy in a sustainable way.
Negative pressure wound therapy (NPWT) is an advanced therapy that has been used for
treating chronic wounds since it was introduced in the early 1990’s.11 NPWT consists of
a machine which exerts a carefully controlled suction (negative pressure) attached to a
wound dressing that covers the PrU. NPWT is a technology that is widely used and is
promoted for use on many types of wounds but is not recommended by the Registered
Nurses Association of Ontario (RNAO) best practice guidelines for the treatment and
management of PrU.6,12
Despite widespread use of various advanced therapies in wound care, only a limited
amount of data exists on their cost effectiveness. In review of the literature, only one
cost-effectiveness study for the evaluation of E-Stim for the treatment of PrUs was
identified. In a study by Mittmann et al (2011), the incremental cost-effectiveness of EStim plus standard wound care (SWC) versus SWC alone was estimated in a spinal cord
injury population with stage III/IV PrUs from the public payer perspective.13 Cost
analysis was conducted using the cost data and healing probabilities from a randomized
controlled trial of E-Stim plus SWC versus SWC alone.14 SWC included using advanced
wound dressings for local wound treatment. They found that E-Stim plus SWC were
associated with better outcomes and lower costs with a 16.4 % increase in the PrUs
healed and a cost saving of $224 at 1 year. E-Stim plus SWC had higher effectiveness
and lower costs than SWC alone and was therefore considered a dominant strategy.15
Despite this evaluation, E-Stim continues to be underutilized as an advanced therapy for
PrU treatment. The study by Mittmann et al demonstrated the benefits of E-Stim using a
one-year timeline; however, PrUs may be present for many years in clinical practice and
a one-year analysis may not capture the true value of using E-Stim.
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The cost effectiveness of NPWT in comparison to advanced wound dressings has been
investigated. Braakenburg et al conduced a cost comparison study by assessing the
clinical efficacy and cost of NPWT versus advanced wound dressings in acute and
chronic wounds in a hospital in the Netherlands.16 They reported no significant
difference in healing rates or costs between the two groups. Dowsett et al also evaluated
the economic benefits of NPWT in a variety of wound types in the community sector.17
NPWT use and resources in the community in the United Kingdom was tracked over a
16-month time period. They calculated the mean cost per episode (£818) over the
average number of days for NPWT. They concluded that the average cost of treating
complex wounds using NPWT could be significantly less than using traditional dressings
by saving nursing time to complete the dressing changes.
Soares et al(2013) conducted a cost-effectiveness analysis on NPWT for the treatment of
PrUs, recognizing NPWT as a treatment that was widely used for PrUs.18 They evaluated
the use of NPWT for the treatment of PrUs given a range of alternative treatments using a
decision analytic model. A literature search was completed for model inputs and given
the limited evidence in the literature; the authors also elicited judgments from experts
using formal elicitation exercises as well as data derived from a pilot trial.19 The three
sources of evidence were collated and the impact of each on cost-effectiveness was
evaluated. They used a model based on three transition states: unhealed, healed and
dead. The authors concluded that when all evidence sources were combined, NPWT was
expected to be less costly and more effective than advanced dressings alone; however,
they recommended that a randomized controlled trial with long term follow up would be
beneficial to reduce decision uncertainty in their model.
Economic evaluations for the treatment of PrUs using advanced technologies are scarce
and clinical studies that directly compare two different advanced therapies do not exist.
Best practice guidelines used clinical research evidence to identify and recommend which
advanced therapies should be used in the treatment of PrUs. It is important to not only
evaluate their clinical effect on healing, but also consider the economic value of these
therapies.6–8
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The aim of this study was to estimate the cost effectiveness of two advanced therapies
using cost utility analysis to calculate outcomes in units that could be compared using
cost per quality assisted life years (QALY). There are no known studies comparing the
clinical effectiveness of E-Stim versus NPWT, therefore two decision analytic models
(DAM) were designed. The cost effectiveness of E-Stim and NPWT versus SWC for the
treatment of PrUs from a health care resource perspective was determined.

3.2 Methods
The DAMs were constructed using Tree-Age Pro Software Inc, version 2018. A DAM of
E-Stim versus SWC was developed based on a previous meta-analysis conducted by Koel
and Houghton including both published and unpublished data (see Appendix 5).20 An
extensive literature search did not reveal a meta-analysis on the use of NPWT for the
treatment of PrUs. Therefore, the DAM for NPWT versus SWC was based on a
randomized controlled trial by Ford et al, 2002.21 These studies were chosen since they
both reported the number of PrU wounds healed. Demographic characteristics of the
patient population were not included in the meta-analysis; therefore, the starting mean
age of 48 was used in the models which was the mean age of participants in the NPWT
study and ran until age 90. Both models were run for a cohort of 1000 patients treated
with each of the wound management regimens considered. The models assumed that,
except for the treatment regimen, all other characteristics of the patients treated were
equal (e.g. wound size, wound duration, and other treatments such as PrU offloading,
etc.). The perspective of the study is that of the MOHLTC and no attempt was made to
capture any indirect costs associated with PrUs.
In both models, individuals received E-Stim or NPWT versus SWC for six weeks. SWC
was defined as the use of basic or advanced wound dressings for local wound
management. If the PrU did not heal or patients suffered a recurrence, the patient
transitioned through various health states using Markov modeling. Markov models
predict how a patient or group of patients with a particular condition progress through a
number of defined health states.15 At the end of a predefined period, individuals can
remain in one health state or move from one health state to another, according to
transition probabilities. Markov models are particularly useful in modeling conditions
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which can be categorized by a number of discrete health states, and for chronic
conditions such as PrUs.15 The structure of the Markov model for this study is illustrated
in Figure 4.

Osteomyelitis
Figure 4: Markov
Model Diagram

Pressure

Dead

Ulcer

Healed

The health states are intended to reflect separate states that an individual with a PrU may
experience. The health states selected in this study were osteomyelitis (OSM), PrU,
healed or dead.
Dead and healed states were included as absorbing states meaning that once individuals
were in the dead or healed states, they could not move out of that state. The duration of
each Markov cycle was defined as 3 months which is a suitable length of time for
individuals to move between each of the health states based on clinical practice. Data
utilized to build the model were converted as required using the following equations:
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Rate= -ln (1-p)/t
Probability=1-exp(-rt)
Where p=probability, t=time, r=rate
In some instances, the progression in between disease states was zero if it is not clinically
feasible. For instance, individuals with OSM cannot progress directly to a healed state.
The DAM assumes that individuals would first progress to the PrU state before
progressing to the healed state. The model structure allows for the recurrence of a
pressure injury once healed, and the recurrence of OSM. The model arms were identical
for the E-Stim, NPWT and SWC model arms. An example of one model arm is seen in
Figure 5.
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Figure 5: Decision Analytic Model Arm

3.2.1 Costs and Resource Use
Canadian dollars (2017) were used in this analysis and costs were converted using the
Bank of Canada and Consumer Price Index as appropriate.22,23 One and a half percent
discounting was applied for the reference model in both analyses and a half cycle
correction was applied for the Markov models as recommended by the Guidelines for the
Economic Evaluation of Health Technologies, 2017.24 Only direct medical costs were
considered in both analyses. All cost references and data sources are summarized in
Table 4.
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Table 4: Treatment Costs
Medical Expense
E-Stim Equipment
NPWT Equipment
SWC
Interdisciplinary
Team
RPN
Hospitalization

Cost
Reference
per day
13.35 Houghton et al,
2010
88.41 Delhougne et al,
2018
9.58 Houghton et al,
2010
38.32 Research Data,
2017
26.39 www.jobbank.gc.ca
1199.60 OCCI

SD

Reference

Distribution

6.04

Houghton et al,
2010
Delhougne et
al, 2018
Houghton et al,
2010
Research Data,
2017
Assumption
OCCI

Gamma

42.51
4.73
19.00
2.64
1911.29

Gamma
Gamma
Gamma
Gamma
Gamma

SD-Standard Deviation; E-Stim-Electrical Stimulation; NPWT-Negative Pressure Wound Therapy; SWC-Standard Wound Care;
RPN-registered practical nurse; OCCI-Ontario Case Costing Initiative

Patients in the OSM and PrU states were assumed to incur costs related to the treatment
of their PrU and the healing of the PrU would be by secondary intention. We did not
include surgical closure as part of the models since this option is seldom available to
patients with PrU in this region.

Costs for E-Stim equipment and SWC were referenced

from the study by Mittmann et al(2011) and converted to 2017 dollars.13 NPWT
equipment costs were calculated using the data from the study by Delhoughne et
al(2018), a retrospective cost minimization analysis of disposable and traditional NPWT
from Medicare claims with costs being converted to 2017 Canadian dollars.25
Interdisciplinary team costs were derived from data collected as part of the E-Stim
Collaboration Project which was described above. These costs are outlined in detail in
Chapter 4. Registered practice nurse (RPN) costs were calculated using data from the
Government of Canada job bank website.26 One hour of nursing time costs were
assumed to be the same as one patient visit for a dressing change. OSM hospitalization
costs were calculated using the Ontario Case Costing Initiative (OCCI) data.27
Multiple assumptions were made to build and compare the two models. Costs for PrU
healed were calculated for a six-week time period for each intervention and total cost was
the cost of the equipment, plus the cost of the interdisciplinary team needed to provide
optimal wound care. Markov state costs are reported in Table 5. For the Markov model
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OSM state, it was assumed that a patient would be admitted to hospital for 24.8 days over
the course of one year which is the average length of stay for patients in Ontario with
pelvic osteomyelitis from OCCI data. 27 When patients in the OSM state were not in
hospital, they were assumed to receive daily dressing changes from an RPN based on
current clinical practice. In the Markov model PrU state, patients were assumed to
receive daily dressings by an RPN. In the healed and dead states, costs were assumed to
be zero. Initial costs for the OSM and PrU states were calculated for patients receiving
E-Stim or NPWT based on clinical practice. Patients who do not heal their PrU after
receiving six weeks of E-Stim or NPWT were assumed to continue with the advanced
therapy for an additional three months prior to being discharged from the advanced
therapy. For NPWT, it was assumed that if a patient entered the OSM or PrU state, they
would receive three months of NPWT to manage symptoms of OSM or as a trial period
for the treatment of the PrU. If the patient remained in the OSM or PrU state for longer
than three months, the PrU was assumed to be a non-healing or non-healable. A nonhealing wound is defined as a wound that has healing potential, but causes and co-factors
that can interfere with healing have not yet been removed and a non-healable wound is
defined as a wound where causes and co-factors that can interfere with healing cannot be
removed, e.g., in cases of terminal disease or end-oflife care.28 Patients with non-healing
or non-healable wounds receive SWC and are discharged from advanced wound therapies
due to their low probability that their wound will heal. For the E-Stim model, it was
assumed that if a patient had a PrU, they would receive three months of E-Stim as a trial
period. If the patient remained in the PrU state for longer than three months, the PrU was
assumed to be a non-healing or non-healable wound and therefore E-Stim would be
discharged.
Table 5: Costs per Three Months Based on a Given State
State
cOSM State
cPrU State
ctransition 3mon NPWT
ctransition 3mon E-Stim

Cost
10496.75
3282.26
7426.44
1926.12

SD
11858.95
431.68
3570.84
644.42

Distribution
Gamma
Gamma
Gamma
Gamma

cOSM-cost osteomyelitis; cPrU-cost pressure ulcer; NPWT-negative pressure wound therapy; E-Stim-electrical stimulation
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3.2.2 Effectiveness
The primary outcomes of both analyses were healthcare costs per QALYs gained. A
literature review was conducted to select the clinical inputs for the model including
recurrence rates, rates for progressing to OSM, rates for progressing to death, and utility
rates. Search terms were derived to capture information on the effectiveness of E-Stim
and NPWT. References used in this analysis focused on the clinical effectiveness of
healing rates for each of the treatment regimens and are summarized in Table 6 and 7.
Table 6: Economic Model Clinical Inputs: E-Stim versus SWC
Variable

Value

Unit

PrU healed with E- 56.0
Stim
PrU healed with
21.3
SWC
Recurrence
38.0

%

Develop OSM

24.5

%

E-Stim Healed

5.29

QALY

SWC Healed

5.00

QALY

%
%

Reference and
Year
Koel and
Houghton, 2013
Koel and
Houghton, 2013
Bates-Jensen et
al, 2009
Darouiche et al,
1994
Sugarman et al,
1983
Assumption from
Model
Assumption from
Model

Distribution
Beta
Beta
Beta
Beta

Gamma
Gamma

PrU-pressure ulcer; E-Stim-electrical stimulation; SWC-standard wound care; OSM-osteomyelitis; QALY-quality adjusted life year
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Table 7: Economic Model Clinical Inputs: NPWT versus SWC
Variable

Value

Unit

Distribution

%

Reference and
Year
Ford et al, 2002

PrU healed with
NPWT
PrU healed with
SWC
Relapse

10.0
13.0

%

Ford et al, 2002

Beta

38.0

%

Beta

Develop OSM

24.5

%

NPWT Healed

4.49

QALY

SWC Healed

4.71

QALY

Bates-Jensen et
al, 2009
Darouiche et al,
1994
Sugarman et al,
1983
Assumption
from Model
Assumption
from Model

Beta

Beta

Gamma
Gamma

PrU-pressure ulcer; NPWT-negative pressure wound therapy; SWC-standard wound care; OSM-osteomyelitis; QALY-quality
adjusted life year

Efficacy rates (% of patients with completely healed PrUs) for E-Stim were obtained
from unpublished meta-analysis data by Koel and Houghton, 2014 that was calculated for
seven studies with a total of 412 stage III/IV PrUs.20 They found 57.2% of participants
completely healed with E-Stim versus 21.3% of participants who received SWC. The
average duration of E-Stim treatment at 7.25 weeks. The rate of healing was assumed to
be the same for six weeks of E-Stim treatment to keep the treatment time prior to entering
the Markov states similar in the two models.
Efficacy rates for NWPT were obtained from Ford et al, 2002 who reported 10% of
participants with PrUs completely healed using NPWT versus 13% of participants with
PrUs who completed healed using SWC alone over a six-week treatment period.
Recurrence was defined in the model as recurrence of a PrU after healing. A value for
the probability for a recurrence was estimated based on a study by Bates-Jensen et al,
2009. The authors reported that 24 out of 64 veterans had a recurrence of a stage III/IV
pelvic PrU in a nine month follow up period.29 This study was selected given the lack of
published Canadian PrUs recurrence rates, and it was used in previous economic
analyses.13 The recurrence rate was assumed to be identical between all treatment arms.
The prevalence of osteomyelitis for patients with PrUs is between 17%30 to 32%.31 The
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mean of the studies by Darouiche et al, 1994 and Sugarman et al, 1983 was used in the
models since these studies continue to be routinely referenced in the current literature as
the prevalence of OSM for individuals with chronic PrU.

3.2.3 Transition Rates
Transition probabilities between each health state and the converted Markov model
probabilities are shown in Table 8. The transition probability for the OSM state was
derived from a study by Bodavula et al, 2015 who performed a retrospective cohort study
of adult patients with PrUs and pelvic OSM from 2006 to 2011.32 In this study, 120 of
220 patients diagnosed and treated with OSM were readmitted with OSM equating to a
probability of 54.5% recurrence over six years. The transition probability of PrU to Dead
was referenced from the article by Lynder et al, 2012, who completed a retrospective
analysis of hospital-acquired PrUs and reported on the risk of mortality with PrUs within
30-days of being discharged from the hospital.33 OSM to Dead transition probabilities
were derived from the study by Huang et al, 2016 who evaluated the risk of mortality in
the elderly who have been diagnosed with chronic OSM.34 The transition probabilities of
PrU to healed was obtained from the Koel and Houghton, 2014 and Ford et al, 2002
studies for the applicable DAM.20,21
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Table 8: Yearly Transition Probabilities in Both Models
Variable
pOSM to Death
Age 70

%
0.7

Reference
Huang et al, 2016

Distribution
Beta

1.1
80
>85 1.4
pPrU to Death
2.0
pOSM stay OSM
4.2
pPrU to Healed E- 84.0
Stim

Lynder et al, 2012
Beta
Bodavula et al, 2015 Beta
Houghton et al,
Beta
2010

pPrU to Healed
SWC

40.5

Houghton et al,
2010

Beta

pPrU to Healed
NPWT
pPrU to Healed
SWC

20.3

Ford et al, 2002

Beta

26.1

Ford et al, 2002

Beta

pOSM-probability of osteomyelitis ; pPrU-probability of pressure ulcer ; E-Stim-electrical stimulation ; SWC-standard wound
care ; NPWT-negative pressure wound therapy ; SWC-standard wound care

3.2.4 Utility Values
Utility values for individuals in the community with PrUs have not been published.
However, Thein et al, 2009 evaluated the health status utilities in long-term care residents
in Ontario both with and without PrU on health-related quality of life (HRQOL).35 Essex
et al, 2009 studied the impact of pressure ulceration on health-related quality of life for
hospital inpatients in the United Kingdom.36 The mean utility scores of these two studies
were used in the models and assumed to be similar to the community PrU population and
shown in Table 9. QALYs in the healed terminal mode in the decision tree were assumed
to be the same as the QALYs for the healed absorbing state in the Markov model.
Table 9: Utility Values
EQ-5D Index
Scores
Markov Model

With PrU

Without PrU

Reference

Distribution

0.225 (0.35)

0.42 (0.36)

Thein et al,
2009
Essex et al,
2009

Beta
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3.2.5 Cost-Effectiveness Analysis
The cost-effectiveness of managing patients with an advanced therapy compared with
SWC alone was calculated as the difference between the expected costs of the two
strategies divided by the difference between the expected outcomes between the two
strategies. The relative cost effectiveness of E-Stim and NPWT was defined as the cost
per QALY gained. If a treatment resulted in an improved outcome for less cost, it was
defined as a “dominant treatment”. A treatment is considered dominant when one
treatment has a higher effectiveness and lower cost than its comparator.15 The
willingness to pay (WTP) values a health gain in terms of the amount a person is willing
to pay to obtain the health gain.37 The WTP threshold chosen for this analysis was
$50,000 per QALY which is frequently referenced in the literature.38

3.2.6 Sensitivity Analyses
Deterministic sensitivity analyses (DSA) were performed to identify how the cost per
QALY gained with using E-Stim or NPWT would change by varying different individual
parameters in the models. For the E-Stim versus SWC model, cost for E-Stim was
increased, probability of PrU healing was decreased, and probabilities of recurrence rates
were decreased by a rate of 25%. For the NPWT versus SWC model, costs for SWC
were increased, probability of healing was decreased, and probabilities of recurrence
rates were decreased also by a rate of 25%.
Probabilistic sensitivity analyses (PSA) were undertaken to assess uncertainty in the
model inputs using Monte Carlo simulations (1000 iterations of the model) by
simultaneously varying the probabilities, unit costs, resource use values and utilities
within the model. Probabilities were varied according to a beta distribution using
expected values of population size and occurrences, utilities were varied according to a
beta distribution using means and standard deviations. Costs were varied randomly,
according to a gamma distribution using means and standard deviations.
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3.3 Results
3.3.1 E-Stim versus SWC
Patients who receive E-Stim for the treatment of PrUs benefit from an additional 0.2
QALYs at an incremental cost of $3675.82 less than SWC (Table 10). The cost analysis
determined that E-Stim is dominant over SWC since E-Stim treatment is less costly but
more effective in comparison to SWC. The cost for treating a patient with a PrU using
SWC alone was $7976.02 with an effectiveness of 5.14 QALYs. The cost for treating a
patient with a PrU using E-Stim was $4300.20 with an effectiveness of 5.34 QALYs (as
shown in Figure 6). The Markov model predicted that 96.8% individuals with a PrU
receiving E-Stim would be healed compared to 80.9% of individuals receiving SWC
alone after one year (Table 11).
Table 10: ICER Value E-Stim versus SWC
Cost
SWC
E-Stim

7976.02
4300.20

Incremental
Costs
3675.82

Effectiveness

ICER

5.14
5.34

dominated

Table 11: Number of Patients in Each Health State after 1 year in the Markov
Model for a Cohort of 1000 Patients (%)
OSM
E-Stim versus SWC model
E-Stim
0
SWC
1.0
NPWT versus SWC model
NPWT
2.2
SWC
1.8

PrU

Healed

Dead

0
13.8

96.8
80.9

2.5
4.2

38.5
29.4

53.8
63.7

5.5
5.1

OSM-Osteomyelitis; PrU-Pressure Ulcer; E-Stim-electrical stimulation; SWC-standard wound care; NPWT-negative pressure wound
therapy
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Figure 6: Cost-Effectiveness of E-Stim versus SWC
Using DSA for multiple parameters, E-Stim continued to be dominant versus SWC
(Figures 7-9). In the PSA, 65.3% of the total iterations resulted in Incremental Cost
Effectiveness Ratios (ICERs) that were economically dominant for E-Stim and an
additional 31.0% of iterations were below the WTP threshold which is most commonly
set at $50,000. Thirty-eight percent of iterations were greater than the $50,000 per
QALY threshold (Table 12). A visual representation of the probabilistic sensitivity
analysis is shown using an ICER Scatterplot (Figure 10). Scatterplots are useful to
visually demonstrate the amount of uncertainty by plotting the data into quadrants. In the
E-Stim versus SWC scatterplot, most data points fall in Quadrant 1 showing that E-Stim
is dominant over SWC. All points fall below the $0.00 line showing that E-Stim is
always less costly than SWC.
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Table 12: ICER Report E-Stim versus SWC
COMPONEN
T
C1
C2

QUADRAN
T
IV
I

C3

III

C4

I

C5

III

C6
Indifferent

II
origin

ICER
Superior
ICER<50000.
0
ICER>50000.
0
ICER>50000.
0
ICER<50000.
0
Inferior
0/0

FREQUENC
Y
652
0

PROPORTIO
N
0.652
0

38

0.038

0

0

310

0.31

0
0

0
0

ICER-Incremental Cost Effectiveness Ratio; E-Stim- electrical stimulation; SWC- standard wound care

Figure 7: Pressure Ulcers Healed with Electrical Stimulation Treatment Decreased
by 25%
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Figure 8: Electrical Stimulation Cost Increased by 25%

Figure 9: Pressure Ulcer Recurrence Rate Decreased by 25%
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Figure 10: Incremental Cost-Effectiveness Ratio Scatterplot: Electrical Stimulation
(E-Stim) versus Standard Wound Care (SWC)

3.3.2 NPWT versus SWC
Patients who receive NPWT for the treatment of PrUs decreased 0.14 QALYs at an
incremental cost of $7041.56 for NPWT over SWC resulting in SWC being the dominant
intervention for the treatment of PrUs in the second model (Table 13). The cost for
treating a patient with a PrU using SWC was $12,379.69 with an effectiveness of 4.94
QALYs. As shown in figure 11, the cost for treating a patient with a PrU using NPWT
was higher than SWC ($19,421.25) and the QALYs was lower (4.80). For individuals
that did not heal within the six-week period and have a PrU or recurrence, the Markov
model predicted that 53.8% of PrUs would be healed using NPWT compared to 63.7% of
individuals receiving SWC alone after one year (Table 11).

Table 13: ICER Value NPWT versus SWC
Cost
SWC

12379.69

Incremental
Costs

Effectiveness
4.94

ICER

57

NPWT

19421.25

7041.56

4.80

dominated

ICER- Incremental cost effectiveness ratio; NPWT-negative pressure wound therapy; SWC- standard wound care

Figure 11: Cost-Effectiveness of NPWT versus SWC
Using the deterministic sensitivity analysis for multiple parameters, SWC continued to be
dominant versus NPWT (Figures 12-14). In the probabilistic sensitivity analysis, 44.9%
of the total iterations resulted in ICERs where NPWT was costlier than SWC but below
the WTP threshold, 5% of the total iterations where NPWT was less costly than SWC but
above the WTP threshold, and 24.5% of the total iterations resulted in ICERs that were
economically inferior for NPWT (Table 14). The ICER Scatterplot for NPWT versus
SWC is shown in Figure 15. Most of the data points fall into quadrants 2, 4, and 6 above
the $0 line indicating SWC is less costly than NPWT in most instances.
Table 14: ICER Report NPWT versus SWC
COMPONEN
T
C1

QUADRAN
T
IV

ICER
Superior

FREQUENC
Y
9

PROPORTIO
N
0.009
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C2

I

C3

III

C4

I

C5

III

C6
Indifferent

II
origin

ICER<50000.
0
ICER>50000.
0
ICER>50000.
0
ICER<50000.
0
Inferior
0/0

449

0.449

1

0.001

291

0.291

5

0.005

245
0

0.245
0

ICER-incremental cost effectiveness ratio; NPWT-negative pressure wound therapy; SWC-standard wound care

Figure 12: Pressure Ulcers Healed with Standard Wound Care Decreased by 25%
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Figure 133: Standard Wound Care Costs Increased by 25%

Figure 144: Pressure Ulcer Recurrence Rate Decreased by 25%
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Figure 15: Incremental Cost Effectiveness Ratio: Scatterplot Negative Pressure
Wound Therapy (NPWT) versus Standard Wound Care (SWC)

3.4 Discussion
Using the decision analytic framework for E-Stim versus SWC, the use of E-Stim for the
treatment of PrUs was dominant over SWC. By contrast, in the decision analysis that
compared NPWT to SWC, the use of SWC for the treatment of PrUs was dominant over
NPWT. The analysis of the two models demonstrates that from a cost-utility perspective,
E-Stim is the most cost-effective treatment for the healing of PrUs. This finding is
supported by treatment recommendations made in multiple best practice guidelines.6–8
The results from this study are based on a DAM that combines a decision tree with a
Markov model, which is a new approach to estimate and compare the cost for two
treatment interventions for PrUs. This approach was used since it most closely mimics
clinical pathways for individuals with PrUs receiving treatment in home and community
care (HCC). Patients who are diagnosed with PrUs are provided SWC and advanced
therapies such as E-Stim or NPWT. The decision as to which treatment they receive is
determined by the physician or nursing health care provider in the home. Patients that
progress to healing utilizing the initial treatment intervention are discharged from HCC
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services. Patients who do not heal their PrU or have a recurrence of their PrU, progress
to the chronic disease states of OSM or PrU and continue to require HCC. Our model
allowed for patients to follow the decision tree arm for six weeks, and if not healed, a
Markov model was applied for the chronic states.
This paper was also unique in its use of two models in order have a common parameter of
QALYs to compare two PrUs advanced treatments. There are no known research papers
that directly compare E-Stim to NPWT and therefore each was analyzed separately using
SWC as the comparator. The evidence for the use of E-Stim for the treatment of PrU was
taken from a meta-analysis because it is the highest level of evidence and therefore
considered to be the most accurate in its ability to determine the number of PrUs healed
with use of E-Stim versus SWC.20 For the NPWT analysis, no meta-analysis that
compared NPWT to SWC using number of healed PrU was available. Therefore, a
randomized controlled trial (RCT) was used.21 With both therapies, the highest level of
available evidence was chosen.
In order to assess for the variables of number of PrUs healed, length of time to PrU
healing, and recurrence rates, sensitivity analysis was conducted for both models using
one-way sensitivity analysis of 25%. After sensitivity analysis the results remained
similar for the E-Stim versus SWC and NPWT versus SWC. Specifically, E-Stim
remained dominant over SWC, and SWC remained dominant over NPWT in all the
explored scenarios.
The results from the DAM for E-Stim versus SWC showed that after one year,
individuals receiving E-Stim for the treatment of PrU’s would be healed in 96.8% of
cases versus 80.9% of cases treated with only SWC. These estimates are significantly
higher than the estimates found in the study by Mittmann et al, 2011 who reported that
after 1 year of treatment with E-Stim, an average of 20.8% of individuals with a PrU
would be healed compared to an average of 4.5% of individuals receiving SWC alone.
We used healing rate probabilities for E-Stim and SWC which were much higher than the
RCT data used to build the model in the study by Mittmann et al.
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The cost for the predication of healing with the use of E-Stim over six weeks was found
to be $2572.50. The results are similar to a recently published Ontario Health
Technology Advisory Committee (OHTAC) analysis which reported that when E-Stim
was administered by a health care professional for the treatment of PrU, cost per patient
ranged from $712 in long-term care to $2,572 in home care. When administered by a
patient or caregiver, cost per patient was $179.00 CDN (2017).39 OHTAC predicted the
need for $0.77 to 3.85 Million yearly costs to implement E-Stim for the treatment of PrUs
in Ontario. Contrary to the results in the OHTAC review, we found that the addition of
E-Stim for the treatment of PrUs is cost effective given it is dominant over SWC.
The cost for the healing of PrU in six weeks with NPWT was estimated to be $5322.66
which is comparable to the average cost to heal multiple types of wounds using NPWT of
$4650.00 US reported by Delhougne et al, 2018.25 We attempted to use the costing data
and QALY data to determine cost per QALYs gained for the use of NPWT as an advance
treatment versus SWC since this has not been previously reported in the literature. Due
to SWC being a dominant treatment in comparison to NPWT, we were unable to report
on cost per QALYs gained. These findings contrast with previous cost studies which
showed NPWT was a cost-effective treatment for PrUs.16–18
This research uses a novel approach by linking a decision tree and Markov model for cost
analysis of two advanced therapies for PrU treatment. Using this decision analytic
model, cost analysis was able to closely mimic outcomes that are based on clinical
practice. This approach for the costing of wound care treatment also can also allow for
the evaluation of healing, non-healing and non-healable wounds in the same model which
may be useful in future research.

3.5 Conclusion
From an Ontario health system perspective, the use of E-Stim for the treatment of PrU’s
is a cost-effective intervention whereas using NPWT to treat PrU’s is not cost-effective
when compared to standard wound care practices without an advanced therapy. This
study supports the need for increased knowledge translation for the use of E-Stim in the
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treatment of PrUs as an intervention that supports best practice and cost effectiveness in
this patient population.
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4

Cost of Pressure Ulcer Care for Individuals Living in the
Community with a Mobility Impairment
4.1 Introduction
Pressure ulcers (PrUs) are a common complication occurring across all sectors of health
care including hospitals, long term care, and home and community care.1–3 A PrU is a
localized injury to the skin and/or underlying tissue usually over a bony prominence, as a
result of pressure, or pressure in combination with shear.4 The severity of PrUs has been
described by the National Pressure Ulcer Advisory Panel’s Staging system, with a Stage
IV PrU representing a more severe and deeper wound.4 PrUs often occur in those with
mobility impairment and are a common secondary health complication for individuals
with spinal cord injury (SCI).5,6 PrUs result in a decreased quality of life7–9 and increased
mortality rates.10–12 PrUs also cause a large financial burden to the health care system.
Bennett et al, 2004 evaluated the cost of patients in a hospital or long term care setting in
the United Kingdom and found the mean cost of healing a single stage III PrU was
7,313£ and rose to 10,551£ if the patient had a Stage IV PrU.13 Brem et al, 2010 also
evaluated the cost of PrUs in a hospital setting by conducting a retrospective chart review
of 19 patients with PrUs who were admitted over a 29 month period to a university based,
tertiary-care hospital in the USA.14 The total hospital costs for a community-acquired
PrU was $124,327US. Chan et al, 2013 conducted a similar study while patients with
PrUs were admitted to acute care hospitals in Canada.15 Specifically, they used an
administrative database called the Ontario Case Costing Initiative (OCCI) to evaluate the
net cost of PrUs that were either present prior to admission or occurred during admission
to acute hospitals. Over a 5-year period (2002-2006), 1351 with hospital acquired PrUs
and 2524 people with community acquired PrUs were identified and compared to a
similar matched group of elderly patients (>65years of age) without PrUs. The total net
adjusted hospitalization cost of treating someone with a stage II – IV PrU ranged between
$11,000 and $90,000 CDN with higher costs for people with more severe PrUs (stage IV)
and with hospital acquired ulcers. These results provide estimates of the additional costs
incurred by hospitals for patients with PrUs, however, this does not provide a value for
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the total cost of a PrU to other parts of the Canadian health care system and to society in
general.
Costs of living in the community with a PrU have been explored as part of a pragmatic
clinical research trial conducted in a small urban center in Ontario, Canada.16 Health care
costs associated with community based PrU care was gathered for 12 community
dwelling individuals living with SCI and PrUs who were followed for a 7-month period.
Using unit costs from publicly available sources, they estimated an average incremental
cost of $4745 +/- 9270 per month in 2011 Canadian dollars. Values per patient were
markedly different depending on whether they required emergency room visits (5
patients) or hospital admissions (2 patients). However, these cost estimates did not
include any out-of-pocket expenses or costs associated with wound care equipment or
supply costs. A case study published by Allen and Houghton in 2004, estimated the cost
of treating a stage III PrU in the community was $9000 per month Canadian dollars. This
case did include lost wages, wound care supplies and equipment rental costs.17
There is very limited information about the cost of treating chronic PrUs occurring in
people living in the community. Most cost estimates published to date use administrative
databases and aggregate data rather than patient level data that is collected prospectively
to identify the number or type of resources used. The objective of this study was to
determine the cost of PrU care in a representative sample of individuals living in the
community with a mobility impairment. We used cost diaries to follow patients who had
been living with a chronic PrU allowing for a cost estimate of “real life” practice. Costs
were evaluated from a ministry of health and long-term care (MOHLTC) and societal
perspective.

4.2 Methods
4.2.1 Population
The population cohort was obtained as part of a multi-year knowledge mobilization
project called the E-Stim Collaboration Project aimed to promote the uptake of best
practices related to PrU care including the use of an advanced therapy called E-Stim.
Participants were identified with mobility impairment including SCI who lived in the
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community, had an open PrU (>1cm2), and were receiving publicly funded home care
services. Within this region, health care is coordinated by the South West Local Health
Integrated Network (South West LHIN) which is funded by the MOHLTC. The South
West LHIN provides home care services by contracting several provider agencies that
employ nurses, allied health professionals, as well as unregulated support workers.
Ethics approval was obtained from the Western University Health Science Research
Ethics Board (REB # 106157), the Lawson Health Research Institute Research Ethics
Board, and the Ethics Committee of participating agencies (see Appendix 3 and 4).

4.2.2 Resource Utilization
Participants who signed a written consent form underwent an in-home initial
comprehensive PrU assessment which included a cost diary. All cost diary data was
collected in person with participants conducted by the same lead author. Costs were
analyzed from a MOHLTC and societal perspective including government assistance,
patients and informal caregivers. Participants were instructed to answer cost diary
questions based on recall for the six-month period prior to the initial assessment. They
were also asked to indicate if they felt the costs they identified were related to their PrU.
The following resources were collected (i) emergency room (ER) visits, (ii) inpatient
hospitalization stays, (iii) family physician visits, (iv) physician specialist visits, (v) clinic
visits, (vi) private pay nursing and allied health practitioner visits, (vii) laboratory tests,
(viii) diagnostic imaging, (ix) medications, (x) paid employment time lost, (xi)
homemaking or volunteer time lost, (xii) assistance with daily activities time (xiii) and
cost of items purchased for pressure injury management. Home and community care
(HCC) costs were provided for each enrolled participant using South West LHIN case
costing database. HCC utilization included the costs of publicly funded wound care
supplies and equipment, and the number of home visits by various health care providers
(nursing, enterostomal therapy (ET), physiotherapy, occupational therapy, registered
dietitian and personal support workers).
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4.2.3 Costs
Sources used to estimate the cost of each item identified by the participants are
summarized in Table 15. Costs for services provided by the publicly funded home and
community care (HCC) were provided by the South West LHIN. Costs for physician
visits, laboratory tests and medical procedures were obtained from the Ontario MOHLTC
Schedule of Benefits, 2015.18 Hospital costs were obtained from the OCCI.(19) ER visit
costs were based on the results by Zoutman et al, 1998 with costs inflated to 2017
dollars.19 These values were also used in the study by Chan et al, 2012 to assess ER visit
costs. Average hourly wages for personal assistance and homemaking was obtained from
the Human Resources and Skills Development Canada.20 Unit costs for medications
were obtained from the Ontario Drug Benefit Formulary. Equipment costs were specific
to out of pocket expenses paid by the participant related to their PrU.
Table 15: Unit Costs and Reference
Unit Costs
Variable
Health Care Professionals
Per visit
Family Physician
Plastic Surgeon
Cardiologist
Physiatrist
Otolaryngologist
Infectious Disease Specialist
Wound Specialists
Urologist
Vascular Surgeon
General Surgeon
General emergency visit
Radiologist
Orthopedic Surgeon
Haematology
Ophthalmology
Medical Oncology
Psychiatry
Gastrologist
Per hour

Unit Cost

$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$

38.35
81.10
157.00
39.00
77.90
157.00
38.35
80.00
90.30
90.30
76.90
50.00
83.10
157.00
82.30
157.00
199.40
157.00

Definition

References

Code A004
Code A085
Code A605
Code H312
Code A245
Code A465
Code A004
Code A355
Code A175
Code A035
Code A100
Code A335
Code A065
Code A615
Code A235
Code A445
Code A195
Code A415

(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
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Average Salary in Ontario
$
Private Pay Services
Naturopath
$
RMT
$
Emergency Room
ER visit per hour
$
Hospitalization (per day)
Pressure Injury infection
$
AAA repair
$
Urinary Tract Infection
$
Dehydration
$
Bowel Obstruction
$
ALC bed
$
Clinic Visits
Pain clinic
$
Wound clinic
$
Walk in clinic
$
Laboratory test and DI (per test)
CBC
$
X-ray hip
$
X-ray chest
$
X-ray leg
$
CT scan hip
$
ECG
$
Urine Culture
$
Wound Swab
$
PICC line
$
MRI
$
Medications
hydromorph contin
$
fentanyl
$
percocet
$
oxyNEO
$
oxybutynin
$
zopiclone
$
lorazepam
$
haldol
$
gabapentin
$
amitriptyline
$
baclofen
$
ratio-Lenoltec
$
tylenol
$

26.08
1,200.00
60.00

(2)
Over 6 months period
cost per visit

358.93
1,030.60
4,020.00
924.41
885.91
1,290.85
842.00
38.35
38.35
38.35
16.00
31.40
32.65
21.30
43.25
11.05
7.00
25.00
168.00
48.35
0.97
3.66
0.13
0.18
0.10
0.22
0.07
0.44
0.04
0.15
0.31
0.05
0.03

Patient report
Patient report
(3)

OCCI code L893
OCCI code I714
OCCI code N390
OCCI code E860
OCCI code K565
CIHI code Z59

(4)
(4)
(4)
(4)
(4)
(5)

Code A004
Code A004
Code A004

(1)
(1)
(1)

Code L393
Code X060
Code X091
Code X063
Code X412
Code G310, G313
Code L641
Code L628
Code Z456
Code J163

(6)
(1)
(1)
(1)
(1)
(1)
(6)
(6)
(1)
(1)

4.5mg Cap
25mcg/hr Trans Patch
5mg/325mg Tab
5mg Tab
5mg Tab
5mg Tab
2mg Tab
5mg Tab
100mg Cap
50mg Tab
20mg Tab
300mg & 15 mg & 15 mg
500mg

(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
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co-citalopram
paroxetine
cymbalta
escitalopram
quetiapine
novo mirtazapine
levofloxacin
ciprofloxacin
xarelto
ferrous gluconate
actonel
cholecalciferol
docusate sodium
levothyroxine
metoprolol
nabilone
oxybutynin
warfarin
senokot
risedronate
biscodyl
salbutamol
colace
fumarate
lactulose
olanzapine
atorvastatin
furosemide
enablex
dutasteride
pantoloc
diltiazen
eliquis
toloxin
celebrex
lansoprazole
rabeprazole
methotrexate
amlodipine
atorvastatin
midodrine

$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$
$

0.13
0.33
0.48
0.33
0.78
0.10
1.37
0.50
2.87
0.04
11.66
2.43
0.03
0.90
0.06
6.78
0.97
0.67
0.03
11.19
0.05
5.00
0.13
0.11
0.01
7.56
0.80
0.04
1.61
0.30
2.08
0.48
1.63
0.21
0.26
0.50
0.13
0.63
0.13
0.80
0.44

20mg Tab
20mg Tab
300mg Cap
20mg Tab
150mg Tab
15mg Tab
500mg Tab
500mg Tab
20mg Tab
300mg
35mg
70mg Tab
100mg Cap
0.025mg
50mg Tab
1mg
5mg Tab
2.5mg Tab
8.6mg Tab
150mg Tab
5mg Tab
100mcg
100mg Cap
300mg Cap
30mLs
20mg Tab
40mg Tab
20mg Tab
7.5mg Tab
20mg Tab
40mg
180mg Tab
5mg
0.125mg Tab
200mg Cap
30 mg Cap
20mg Tab
2.5mg Tab
5mg Tab
10mg Tab
2.5mg Tab

(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
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morphine
nitrofurontoin
venlafaxine
ranitidine
gliclazide
hydrochlorothiazide
rosuvastatin
metformin
losartan
sulfatrim

$
$
$
$
$
$
$
$
$
$

2.09
0.23
0.12
0.12
0.06
0.02
0.14
0.43
0.31
0.15

15mg Tab
100mg
75 mg Cap
150mg Tab
60mg Tab
12.5mg Tab
10mg Tab
500mg Tab
100mg Tab
800mg

(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(7)

4.3 Analysis
HCC costs were provided for 11 participants from South West LHIN case costing
database. For the participants who did not have administrative data provided, the mean
cost for HCC purchased services and purchased items calculated for 11 participants was
used. The cost of zero ($0.00) was used when a participant did not report utilization of a
resource in the cost diary. All cost diary items were entered into a Microsoft® Excel
spreadsheet and average monthly costs per participant were calculated by summing the
total costs over six months for each participant. The overall cost per patient per month
for the 22 participants was calculated using the mean monthly cost for each participant.
Average costs were also calculated based on costs identified as PrU specific and type of
mobility impairment. Sensitivity analysis was conducted on costs subject to variability.
This included HCC costs, hospitalization costs, and purchased equipment costs.

4.4 Results
Twenty-two participants were included in the study (see Table 16). The average age was
58.5 years (+/-15.5) and 68.2% (15/22) were male. Eighty-two percent of were
individuals who had a SCI for an average of 13.8 (+/-11.5) years, with majority (55%)
having only lower extremity involvement (paraplegia). Four people had mobility
restrictions due to other neurological conditions including stroke, Parkinson’s disease,
depression and a below knee amputation. Mean wound duration for the cohort was 21.2
(+/-24.2) months with a mean surface area of 6.6 (7.6) cm2. PrU location included ischial
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tuberosity (50%), coccyx (18.2%), sacrum (13.6%), foot/heel (9.1%), leg from prosthesis
pressure (4.5%) and shoulder (4.5%). Participants had PrUs that were primarily stage III
(40.9%) and IV (50%), one participant was diagnosed with a deep tissue injury, and one
participant had eschar overlying the wound making the wound unstageable.
Table 16: Demographics
Age Mean (SD)
Male/Female (%)
Injury (%)
• Upper SCI (cervical spine injury)
• Lower SCI
• Catatonic Depression
• Below Knee Amputation
• Cerebrovascular Accident
• Parkinson’s Disease
Years with SCI Mean (SD); n=18
Months with PrU Mean (SD)
Wound Surface Area in cm2 Mean (SD)
Wound Site (%)
• Ischial Tuberosity (n=11)
• Coccyx (n=4)
• Buttock (n=3)
• Other (n=4)
Stage of PI (%)
• Unstageable (n=1)
• Deep Tissue Injury (n=1)
• Stage III (n=9)
• Stage IV (n=11)

58.4(15.5)
Male: 68.2; Female: 31.8
27.0
55.0
4.5
4.5
4.5
4.5
13.8 (11.5)
21.2(24.2)
6.6(7.6)
50.0
18.2
13.6
18.2
4.5
4.5
40.9
50.0

Total average monthly costs for a person with limited mobility living in the community
with a PrU were estimated to be $8,247.48 (+/-16,549.35) in 2017 Canadian dollars.
Percentage of monthly costs for each cost diary item is shown in Figure 16.
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HCC-home and community care; ER- emergency room; HCP- health care provider; FP-family physician; HK-housekeeping

Figure 166: Percentage of Average Monthly Costs

Hospitalization costs accounted for 64% of total costs with seven of the 22 study
participants’ having been hospitalized within six months prior to completing the cost
diary. All study participants received HCC services which accounted for 24% of total
costs. Eleven participants reported at least one visit to the ER, 17 participants went to
their family doctor, 15 participants attended at least one specialist physician visit, and
four participants reported having been to a medical clinic. Sixteen participants reported
having had a laboratory test or underwent diagnostic imaging in the previous six months,
and only three participants did not report any prescribed medications, however, all
participants reported they paid out of pocket for supplements such as vitamins that were
recommended to help manage their PrU. Ten participants recalled additional costs paid
for expenses such as transportation or parking in order to attend medical appointments.
Three participants paid out of pocket for private healthcare services including naturopath,
personal support worker and physiotherapist not funded by the MOHLTC. Fourteen
participants reported on out of pocket expenses they paid for equipment such as
wheelchairs, specialized mattresses, dressings, and supplements. Five participants
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reported homemaking, caregiving, or volunteer time lost due to their PrU. Two of the 22
participants were working at the time of the assessment, however only one participant
reported wages lost due to their PrU.
Average cost per month per person was calculated from MOHLTC, social assistance and
out of pocket costs for the patient (see Table 17). Average cost per month per person
with tetraplegia was $10,122.22, with paraplegia was $9,106.06 and with other mobility
impairment was $2,859.62. Cost per month per person when costs were specifically
identified by participants for treatment of their PrU was $3107.73. The average cost of
equipment purchased to manage pressure was $5,584.45 per person.
Table 17: Average Costs per Patient Per Month
Average Costs of Individuals with Mobility Impairment and Pressure Ulcers (N=22)

Ministry of Health and Long-Term Care Costs
HCC Purchased Services
HCC Purchased Items
Emergency Room Visits
Hospital Admissions
Family Physician Visits
Specialist Visits
Clinic Visits
Tests and Lab
Government Subsidized Costs
Medications
Patient “out of pocket” Costs
Additional Costs
Health Care Providers-Private Pay
Lost Wages
Homemaking Time Lost

TOTAL COSTS

Average Cost per
month per person

(Range)

$1478.55
$506.40
$43.51
$5,173.88
$9.88
$23.04
$3.78
$8.93

($402.27-4,155.00)
($157.00-1,807.00)
($0-59.82)
($0-75,040.00)
($0-25.57)
($0-107.70)
($0-38.35)
($0-44.93)

$236.46

($0-1,384.84)

$1.15
$367.27
$23.71
$370.93

($0-8.33)
($0-3,040.00)
($0-521.60)
($0-3,129.60)

$8247.49

$559.27-89,362.74

Table 18 shows the effects of the sensitivity analysis on average monthly costs. Costs
remained relatively similar when there were no costs assumed for unpaid time lost for

79

homemaking, volunteering and caregiving. Monthly costs decreased when no cost for
alternative level of care beds was assumed, no cost for private health care providers was
assumed, and the lowest monthly cost for HCC was used. Monthly costs increased when
it was assumed that the reported equipment was purchased by participants within the last
six months and when the maximum monthly cost for HCC was used.
Table 18: Average Monthly Costs with Sensitivity Analysis
Variable Changed
No costs for unpaid time lost for
homemaking, volunteering and primary
caregiver
Equipment purchased assumed to be within
the last 6 months
No cost for Alternate Level of Care beds
No cost for private Health Care Providers
Minimum HCC costs
Maximum HCC costs

Average Cost per month per person (SD)
$8,054.37 ($16,619.16)

$9,178.22 ($16,368.19)
$7,086.54 ($16,002.06)
$7,880.21 ($16,624.48)
$6,996.62 ($16,452.61)
$11,510.53($16,452.61)

Visits by different health care providers within the HCC system are shown in Table 19.
The median number of HCC nursing visits was 17 per patient per month (range 5-34).
The median monthly visit rate ET visits was one, zero for physiotherapy, one for
occupational therapy, and zero for registered dietitian.
Table 19: Home and Community Care Service Utilization per Participant per
Month

Median
Range

Visiting
Nurse
17
5-34

Enterostomal
Therapist
1
0-2

Physiotherapist Occupational
Therapist
0
1
0-3
0-4

Registered
Dietitian
0
0-2

4.5 Discussion
The results of this study have demonstrated that each individual who has a mobility
impairment resulting in a PrU has an estimated monthly cost of over $8200.00 Canadian
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dollars. For our cohort of 22 patients, whose average wound duration was 21.2 months,
this would result in a total cost of $3,846,624.50 spent at the time of initial assessment.
To our knowledge, this is the first prospective study that used patient level data to
estimate the cost of living in the community with a PrU from a MOHLTC and societal
perspective. In an economic evaluation completed for the Spinal Cord Injury Research
Evidence (SCIRE) evaluating health care resources, the total mean annual cost per
individual with SCI in Ontario is approximately $180,000.16 Our estimate of annual costs
for health care treatments of the SCI group of participants in the present study was
similar at $144,747.54. It is well known that PrUs are often a secondary complication of
chronic disease, and consequently all health comorbidities impact an individual’s ability
to heal their PrU. Therefore, it is challenging to estimate costs specifically associated
with a comorbidity such as PrUs.

In this study, we choose to let participants designate

which costs were directly associated with their PrU. This yielded an average annual cost
of $38,111.88 per person. In addition, when we asked them to estimate out of pocket
expenses for pressure redistribution equipment that they were currently using, an
additional cost of $5,584.45 per person was calculated.
In our study, hospitalization costs accounted for 64% of total monthly costs with seven of
the 22 study participants having been hospitalized within the six months prior to
completing the cost diary. These results are similar to those reported by Chan and
colleagues in 201217 who found the average monthly cost of community-based PrU ulcer
management was $4745 and 62% of these costs were due to hospitalization, 15% due to
healthcare provider costs, and 16% non MOHLTC costs.
Despite the similarities in percentages of both studies, our study estimated a monthly cost
that was $2842.93 higher than the monthly cost reported by Chan et al, 2012 when
converted to 2017 Canadian dollars. This difference is likely because we included more
costs incurred by HCC such as equipment rental and out of pocket health care expenses
of participants. In addition, participants included in the present study had serious medical
conditions (e.g. osteomyelitis) that would have been excluded from previous studies that
followed relatively healthy participants who were recruited into a randomized controlled
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trial. The monthly cost estimate of our study is closer to the $9000/month cost for
treating a stage III PrU in a case study about a person living in the community with a SCI
and PrU21
In evaluating the HCC resource utilization, the median number of nursing visits was 17
per month with a range of 5-34 nursing visits per patient per month. Based on known
practices within HCC in this region, these home visits were likely filled by RPNs who
were changing the wound dressing. By comparison monthly visit rates of other
interdisciplinary team members such as physical and occupational therapists, were very
sparse. This is despite the fact that all the participants in the study had significant
mobility impairments and either used a wheelchair or were bed fast. This demonstrates
that patients in the community with a long standing PrU may not receive the
interdisciplinary team approach recommended in local, national and international best
practice guidelines.22–24
There were several limitations to our study. This report contains only a small sample of
people who have a chronic PrU and are receiving HCC services in this region. Most of
the items included in the cost analysis were based on participant report of the previous six
months of health care interventions and therefore is subject to recall bias. We assumed if
the participant could not recall any resource use in a particular category, that costs were
zero. Cost estimates for health care resources the patient did not pay for (hospital and
HCC costs) have to be based on many assumptions (see Table 15). The exception was
for HCC costs where administrative costs were provided for 11 of the 22 subjects. Costs
captured did not include government funding for assisted living residences which also
funds personal support workers (PSW) support for residents. This would underestimate
the cost of PSW support required for living with a PrU when assistance for transfers is
increased to allow for offloading of the PrU.

4.6 Conclusion
Cost per month for an individual in the community suffering with a PrU is $8247.48 from
a societal perspective. Costs that participants specifically attributed to PrU management
were $3107.73/month. Patients with PrUs require high HCC resource utilization for PrU
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management. Given the significant costs associated with long term PrUs, early
intervention using best practices to maximize healing rates is encouraged.
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5

Cost of a Pressure Ulcer with Underlying Osteomyelitis: A
Case Study
5.1 Introduction
Pressure ulcers (PrUs) are a common, secondary health complication occurring across all
sectors of health care including hospitals, long term care, and home and community
care.1-3 A pressure ulcer is a localized injury to the skin and/or underlying tissue usually
over a bony prominence, as a result of pressure, or pressure in combination with shear.4
Stage IV PrUs extend into muscle, bone or joint structures and are associated with
considerable morbidity and mortality.5 PrUs that remain open for months, or even years,
are at risk for developing deep infection including osteomyelitis (OSM). 6,7
Osteomyelitis is inflammation of the bone or bone marrow usually due to infection and is
present in 17-32% of patients with PrUs.6,7 This high prevalence is quite staggering
given that OSM underlying PrUs can lead to wound chronicity, complications of flap
reconstruction surgery, increased length of hospital stay, and increased costs.8-10
Diagnosis of PrU related OSM is complex given that clinical assessments are often
inaccurate, and there is no imaging technique (bone scan, X-ray, bone biopsy, MRI) that
allow for an acceptable discernment between OSM and PrU related bone changes.9,11
With little agreement amongst physicians about the best test to confirm the presence of
OSM, patients with suspected OSM can undergo several tests during the diagnostic
process, incur significant delays in treatment which can result in the progression of the
bone involvement. OSM has traditionally been treated with 4-6 weeks of parenteral
antibiotics which can be insufficient to manage these deep and complex infections.12, 13
Repeated antibiotic treatments are often required. Many researchers believe untreated
OSM will prevent wound closure even with the use of best practices for PrU
treatment.6,14,15
Despite important research to date identifying the risks associated with pelvic OSM, most
of research that has evaluated treatments for OSM have focused on surgical interventions
such as surgical debridement and flap reconstruction surgery.10, 12, 13
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There is little known about the cost of treating patients with OSM. In a study by
Hirshberg et al in Michigan, USA; 12 individuals with OSM of the pelvis due to PrU
were examined retrospectively to identify the cost of treatment. They found the average
cost to treat an individual with OSM due to PrU was $59,600US and this cost did not
include the cost of reconstruction surgery.10 Once diagnosed with OSM, the cohort of 12
individuals required a total of 77 courses of antibiotics and 17 surgical debridement. The
majority of debridement occurred in the operating room because of the need for extensive
resection of the bone. Only six of the 12 (50%) individuals had successful closure of
their PrU after receiving surgical flap closure.
The purpose of this paper was to bring a person lens to cost analysis and document a
patient’s lived experience and monthly costs associated with the diagnosis and treatment
of a single case with a PrU and underlying OSM This cost analysis took a health care
resource perspective.

5.2 Methods
“Ms. P” was a participant in a multi-year knowledge mobilization project aimed at
implementing best practices into community based PrU care for individuals with spinal
cord injury (SCI) living in one region of Ontario, Canada. Within this region, health care
is coordinated by the South West Local Health Integrated Network (South West LHIN)
which is funded publicly. The South West LHIN provides home care services by
contracting several provider agencies that employ nurses, allied health professionals, as
well as unregulated support workers. Participants who consented to participate in the
study underwent an in-home initial comprehensive PrU assessment by the lead author,
which included a cost diary. Ethics approval was obtained from the Western University
Health Science Research Ethics Board, REB # 106157, the Lawson Health Research
Institute Research Ethics Board, and the Ethics Committee of participating agencies (see
Appendix 3).
Baseline resource utilization data was collected from the individual during an initial
home assessment using a cost diary. The cost diary documented expenses incurred for
the previous six months. The cost diary included the following items: (i) emergency
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room (ER) visits, (ii) inpatient hospitalization stays, (iii) family physician visits, (iv)
physician specialist visits, (v) clinic visits, (vi) laboratory tests, and (vii) diagnostic
imaging. In home sessions were conducted to complete the cost diary each month from
October 2015 to March 2016 until Ms. P had an MRI to confirm OSM. Ms. P was
reassessed in July 2017 and baseline costs for the previous six months were estimated and
then followed monthly from July to September 2017. A total of 10 cost diaries were
completed over a total period of two and a half years. All cost diary information was
based on recall.
Unit costs and resource use in 2017 Canadian dollars are outlined in Table 20. Home and
community care (HCC) utilization and costs for this individual were obtained from the
South West LHIN database for case costing. HCC costs were provided as cost of
providers per month and cost of equipment/dressings per month. HCC costs were only
provided for this individual at baseline, and therefore monthly HCC costs had to be
assumed to be consistent for the two-and-a-half-year time period. Costs for physician
visits, laboratory tests and medical procedures were obtained from the Ontario MOHLTC
Schedule of Benefits, 2015.16 Hospitalization costs were obtained from the Ontario Case
Costing initiative.17
All cost diary items were entered in to a Microsoft® Excel spreadsheet and average
monthly costs were calculated. For baseline cost diaries, the costs were averaged over
the previous six months to establish a monthly cost estimate. The average monthly cost
over 2.5 years was calculated using the mean cost for the 10 cost diaries.
Table 20: Costs and Resource Use
Unit Costs Expressed in 2017 Canadian Dollars
Variable
Specialist Physician Visits
Family Physician
Plastic Surgeon
Physiatrist
Infectious Disease Specialist

Unit Cost
$
$
$
$

38.35
81.10
39.00
157.00

Utilization over 2.5
years
Definition

References

Code A004
Code A085
Code H312
Code A465

(1)
(1)
(1)
(1)

2
6
3
4
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Wound Specialists
Hospitalization (per day)
Osteomyelitis, pelvic region

$

Code A004

(1)

5

1,239.59 OCCI code
M8695
Laboratory test and Diagnostic Imaging (per test)
CBC
$
16.00 Code L393
Urine Culture
$
7.00 Code L641
Wound Swab
$
25.00 Code L628
PICC line
$
168.00 Code Z456
MRI
$
48.35 Code J163

(4)

46 days

(6)
(6)
(6)
(1)
(1)

3
1
3
5
2

$

38.35

5.3 Results
Ms. P is an active 69-year-old with complete L2-3 paraplegia following a catastrophic
motor vehicle accident that occurred 22 years ago. At the time of initial assessment, Ms.
P reported she was retired, lived alone, and completed her activities of daily living
(ADLs) independently. Ms. P estimated that her wound began 5 years ago, and she had
been receiving daily nursing visits from HCC for dressing changes for the 10 months
prior to the initial assessment. Her PrU was over her ischial tuberosity, measured 0.9
cm2 and gritty bone was palpable in the base of the wound. Over the past 5 years, Ms. P
reported that her wound had repeatedly closed for short periods of time but would recur.
She reported that the copious amounts of drainage and odour coming from her PrU often
made her feel uncomfortable in public areas such as the grocery store.
The total cost incurred to date for this single patient was $237,684.69 during the study
period. The average monthly cost for this individual with a PrU and OSM was $
7,916.70 per month (+/-12,566.96). The ranges in monthly costs were from $1987.08 to
$37,873.65 over a two-and-a-half-year period. Seventy-two percent of total costs were
due to three hospital admissions for a total of 46 days during the last three months of data
collection. These admissions were required to treat septicemia directly caused by
unresolved OSM. Eighteen percent of costs were due to HCC resources, and six percent
due to HCC dressings (Figure 17).
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Figure 17: Allocation of Monthly Costs

Ms. P was clinically diagnosed with OSM during the initial assessment; however, an
MRI to confirm diagnosis required a waiting period of 5 months. Ms. P was referred to
an infectious disease specialist and plastic surgeon for surgical debridement to assist with
management of her OSM. Ms. P reported having multiple courses of long term
intravenous antibiotics while being treated for OSM and requiring five peripherally
inserted central catheters (PICC) lines. Ms. P was also receiving synthetic erythropoietin
injections 3x/week to increase her production of red blood cells.
After following Ms. P for two years, she continued to have two PrUs present. She
developed a second PrU during one of her hospital admissions and at the time of the last
re-assessment she was treated by HCC with negative pressure wound therapy (NPWT)
applied to both PrUs. Ms. P was no longer independent with her bed transfers due to her
inability to use a sliding board. She required use of a hoyer lift with an out of pocket
expense of $4000 for installation. She was unable to drive herself and required personal
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support for her ADLs and iADLs due to her PrUs. This was a drastic decline in her
functional independence compared to her initial assessment in October 2015.

5.4 Discussion
To our knowledge, this is the only prospective study reporting patient level data on the
cost of living with a PrU complicated by OSM. The cost of pelvic OSM treatment from a
public payer perspective is close to $8,000.00 per month for this individual. This cost is
significant with most of costs being due to hospital admission. Most significantly, this
case study highlights the significant impact this complication of PrU has on the quality of
life and independence of an individual living with PrU. Unfortunately, the OSM was
still present in this individual and her PrU were not healed, therefore the costs continue,
and her life continues to be impacted greatly.
Ms. P had three hospital admissions within two months over the two-and-a-half-year
observation period. This is like the results found by Bodavula et al who completed a
retrospective review of 220 individuals who were admitted to a teaching hospital in
Missouri, Illinois with pelvic OSM. They reported that one third of individuals had two
or more readmissions to hospital over the course of one year.18 At the conclusion of our
study, Ms. P had undergone six debridement procedures by the plastic surgeon in the outpatient hospital clinic. No plans for further surgical debridement had been established.
There is much debate about the type and duration of antibiotics and whether surgical
intervention is needed to resolve OSM12–15,19,–20. Unfortunately, there are few studies that
have evaluated the effectiveness of treatments of OSM
Diagnosis of OSM underlying PrU has also been challenging with different methods such
as plain film x-ray, MRI, and bone biopsy being reported in the literature.11,21,22 As a
result many patients undergo several different diagnostic tests and must deal with
conflicting results. Protracted course of OSM diagnosis results in delays in initiating
treatments. Unresolved OSM has the potential to cause further bone involvement and
puts the patient at greater risk of septic shock and even death. .
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At the time of Ms. P’s initial assessment where OSM was suspected, she reported having
had her PrU for five years with periods of short term closure. She had been receiving
daily dressing changes due to copious drainage for 10 previous months. Ms. P was
clinically diagnosed by a specialized team at a local regional rehabilitation centre. Ms. P
continued to wait a further five months for an MRI to radiologically diagnose OSM. Our
case study demonstrated that pelvic OSM underlying PrUs is a clinical condition that is
difficult to diagnose, as well as treat.
In a recent study by Andrianasolo and colleagues, 61 individuals with PrU-related OSM
were evaluated. Patients underwent surgical debridement with flap reconstruction
surgery 6.6 weeks after debridement.13 All of the individuals required intravenous
antibiotics for a mean total of 19.8 weeks. Fifteen treatment failures (23.4%) were
diagnosed 12.4 weeks after flap coverage, with additional surgical procedures required in
14 cases (93.3%). Four patients died, including 2 deaths related to PrU-related infection.
The authors concluded that PrU-related OSM outcomes are poor with an overall failure
rate approaching 25%. Unfortunately, surgical intervention is not always an option for
individuals with OSM because of a lack resources and expertise. Due to limited access
for surgical intervention, pelvic OSM can result in a lifelong disease with a high risk of
death from septic shock.
The cost in our case study is higher than previous monthly estimates found by Chan et al
of $4745.00 to treat community dwelling individuals with SCI and PrUs.23 Further
increasing the discrepancy is that our cost estimate only considers public costs, whereas
Chan’s study estimated costs from a societal perspective. Additionally, our findings may
be an underestimate of costs since it is based on Ms. P’s recall. High rates of health care
resource utilization have been observed in the literature for individuals with SCI, and this
increased resource use is commonly due to secondary complications such as PrUs.(24–
26) In our case study, Ms. P was observed to have only two family physician visits over
two and a half years which is atypical for an individual with SCI and a PrU in reference
to the literature.25
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There is a high cost associated with OSM management in the community, and an even
higher cost when individuals are offered surgical intervention such as flap coverage. Our
case study was an accurate portrayal of individuals who live with PrU and OSM since
opportunities for surgical intervention and the convalescence required post operatively
are scarce in many locations in Ontario, Canada. This case study demonstrates the
clinical reality that PrU with OSM are often a lifelong disease requiring high HCC
resources and frequent hospital admissions for septic infection in immunocompromised
populations such as people with SCI.

5.5 Conclusion
Costs associated with treating PrUs and OSM in the community are significant. A
conservative estimate based on this case study is $8,000 per month per individual. The
cumulative costs from a public payer perspective are staggering considering the
challenges of curing OSM in individuals with PrUs. More needs to be done to prevent
this devastating consequence of PrU including ensuring evidence informed PrU
treatments that are known to promote rapid closure of PrUs.
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6

Thesis Discussion
This research was completed as part of a large, knowledge mobilization project with the
aim of increasing the use of electrical stimulation (E-Stim) as evidence-based practice for
the treatment of pressure ulcers (PrUs). This large, multifaceted project was directed at
introducing practices that would improve wound healing outcomes for patients living
with PrUs. Studies described in this thesis focus on two components of this research: an
evaluation of an education program and cost analyses of pressure ulcer care and E-Stim
use in a community located in South-western Ontario, Canada.
Chapter 2 reported on the outcomes on an education program developed to train health
care providers on the use of E-Stim for the treatment of PrUs. The aim of the study was
to determine if an online E-Stim education program can increase provider’s knowledge
and change attitudes and practice about the use of E-Stim to stimulate healing of chronic
pressure ulcers. Results suggest that knowledge about E-Stim can be improved via a
customized online education program. Measurement of attitudes that determine health
care providers view for the use of E-Stim also improved with the educational program.
Further revealed was that clinicians support the use of E-Stim for the treatment of PrUs,
however additional hands-on training may be required to change practices.
While some attitudes were changed after completing online educational modules, certain
other attitudes required completion of a hands-on workshop. Despite significant
improvements in knowledge and attitudes about E-Stim, very few participants reported to
the research team that they used E-Stim in their practice. While this result is not entirely
unexpected, it suggests that further work is needed to influence practice. It also suggests
other barriers exist that interfere with a clinician’s ability to put new knowledge into
practice.
Another barrier to implementation of an advanced wound care therapy is the perception
that it is too costly. Chapters 3-5 investigate the outcome of cost as part of the E-Stim
Collaboration Project. In Chapter 3 a cost analysis was conducted to evaluate the cost
effectiveness of using E-Stim for the treatment of PrUs. Decision analytic modelling was
used to evaluate the cost per quality adjusted life year of E-Stim and to compare the cost
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effectiveness of this novel therapy to an advanced therapy commonly adopted in practice
called negative pressure wound therapy (NPWT). E-Stim was found to be a dominant
treatment over standard wound care (SWC) meaning it is a less costly and more effective
treatment than SWC. By comparison a second decision analytic model was developed to
compare NPWT to SWC and found adding NPWT was not cost effective compared to
SWC. The cost analysis determined that E-Stim is a cost-effective treatment for PrUs.
Chapters 4 and 5 outline the costs associated with individuals who have a PrU from
MOHLTC and societal perspective. Using cost diaries and specific case costing data, the
monthly costs for a cohort of 22 community dwelling patients with PrU who were
receiving HCC. The average monthly cost was calculated to be $8247.48 per patient .
Chapter 5 provide a case example of the impact when OSM develops in unresolved PrU.
Needless to say, the cumulated costs and health care resources utilized to diagnose and
treat someone who has a PrU that becomes complicated with OSM are astronomical. Not
to mention the devastating effects that having OSM has on a patient’s quality of life.
Considering participants in this study had their PrU for an average of 21 months, societal
costs for unhealed PrU are enormous. This economic evidence provides the kind of
justification that many health care decision makers require before implementing
advanced therapies like E-Stim.
This thesis summarizes challenges in implementing pressure ulcer best practices fot two
main practice drivers: education and costs. This research was guided by the KTA and
NIRN frameworks using a standardized approach to implementation, adaptation, and
practice change using PDSA cycles. Despite this approach to implementation, we were
unable to demonstrate a significant change in practice for the use of E-Stim in the
community. From this work, three key recommendations have been highlighted for
future implementation projects. The first recommendation is to ensure that timing for
implementation is appropriate. During the time of the E-Stim Collaboration Project,
significant government structural changes were occurring within the South West LHIN
which resulted in competing priorities and unclear stakeholder roles. The second
recommendation is to engage stakeholders who are interested and willing to invest a
significant amount of time towards the implementation initiative. Thirdly, establish key
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aspects of the pressure ulcer care prior to implantation. For example, the training
outlined in chapter 2 should have been completed prior to E-Stim implementation. A
detailed account of the E-Stim Collaboration Project implementation challenges, barriers
and facilitators is outlined in the thesis by Lala (2018).1
Implementation of best practices is important, however very challenging. During our
research, we felt we had removed barriers identified by clinicians, such as lack of
education and lack of resources, and maximized facilitators that had been identified at the
beginning of the project. However, community engagement for the use of E-Stim
continued to be elusive. An area of exploration for the increase in E-Stim use may be
that of mentorship in a clinical setting. Establishing not only online and hands on
education, but also mentorship may increase clinician’s confidence in delivering this
intervention to patients. Increased awareness of wound care interventions, specifically at
nursing and physiotherapy schools, could include E-Stim for wound treatment as an early
intervention given that it is a best practice intervention. We were also limited in our
study due to ethics the ability to advertise at a patient level. Engaging patients and
increasing the awareness for the use of E-Stim at a public level may also be a potential
driver for change.
This thesis demonstrates that educational programs are an important intervention to
increase the awareness of best practices, however education is not enough. Despite the
provision of high level evidence that E-Stim is effective to speed the healing of PrUs, we
did not see a significant change in practice. When the cost of best practice treatment
interventions was evaluated, E-Stim was shown to be dominant by being less costly and
more efficient when compared to SWC treatments. This further strengthens the need to
increase the clinical use of E-Stim as a treatment intervention. Chapters 4 and 5 further
show that when best practices are not utilized, PrUs progress to become a large financial
burden to both the health care system.
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Appendix 2: Letter of Information and Consent- E-Stim Education Study

PARTICIPANT
LETTER OF INFORMATION
Title of the study: Evaluation of an Electrical Stimulation Therapy Education Program for the
Healing of Chronic Wounds
Primary Investigator: Pamela Houghton, PhD
Co-Investigators: Lyndsay Orr, MClSc; Paul Holyoke, PhD; Jillian Brooke, MClSc; Deena Lala, MSc
You are being invited to participate in a research study as a health care provider receiving
education on the use of electrical stimulation therapy (EST) for the healing of chronic wounds.
To decide whether or not you want to take part in this research study, you should understand
what is involved. This form will provide you detailed information about the research study.
Once you understand the study, you will be asked to sign the form at the end of this information
letter if you wish to participate.
PURPOSE OF THIS STUDY
Chronic, non-healing wounds are one of the most common secondary health complications
among individuals with immobility or those who require use of a wheelchair. When skin
breakdown occurs, it limits people’s ability to participate in activities and increases the time
they spend in bed, leading to decreases in quality of life. Multiple best practice guidelines
recommend the use of EST to promote the closure of chronic wounds. EST promotes wound
healing by increasing the blood supply into the wound and stimulates the wound healing
process. Current wound care in individuals with neurological conditions living in the community
occurs within the home. However, due to limited knowledge and experience with EST, very few
care providers in the community provide this therapy.
The purpose of this study is to determine whether we can improve health care provider’s
knowledge, attitudes and practice (KAP) in the use of EST to improve the healing of chronic
wounds.
WHAT WILL BE ASKED OF YOU IF YOU PARTICIPATE
If you agree to participate in this study, you will participate in the following:
1. Questionnaire & Pre-test: You will be asked to complete a brief questionnaire and a
knowledge test prior to receiving education on the use of EST. This test helps us
understand your current situation and evaluates your level of knowledge. The
questionnaire and pre-test should take no more than 15 minutes to complete.
2. Educational modules: You will then complete 4-6 educational modules that will be
available via a secure website or delivered in person by a lecturer. Either of these
learning opportunities will take approximately 4-6 hours to complete. The lectures will
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3.

4.

5.
6.

be scheduled during a one-day workshop to be provided at a mutually convenient
location and time. Online modules will be provided via internet so that they can be
completed at your own pace.
Hands on Workshops: Once you have completed the education you will be able to
attend a one-day hands-on practice session that will provide you an opportunity to
practice application techniques and use equipment needed to use EST for wound care.
Case based discussions will also occur in small groups that will advance your knowledge
about EST and promote good clinical judgement that supports safe and effective clinical
practice.
Post-test: You will be required to complete a post-test after receiving education on the
use of EST to evaluate your new knowledge. This knowledge test will also be repeated
after the hands on clinical skills session. The test will take approximately 15 minutes to
complete.
Upon completion of this education, you will receive a certificate of achievement.
Post-test 2: You will be asked to complete a second test 6 months after completing the
EST education. This test will allow us to evaluate the knowledge you have retained and
what practices have been incorporated into your clinical practice. This test will be
approximately 15 minutes in length.

You will be assigned a unique number identifier in order to track your test results. The results of
your test will not influence your ability to receive a certificate of achievement upon completing
the EST education. Both post-tests will ask for your feedback about the education received. The
feedback you provide in the questionnaires will only be shared with the members of the
research team.
POSSIBLE RISKS
There is the potential to encounter technical difficulties when completing the online modules.
In such cases, technical support will be provided to ensure a working system is available.
BENEFITS
The benefit for participating in this study is the ability to provide valuable feedback to develop a
comprehensive educational platform for the use of EST in the healing of pressure ulcers. The
information collected in this study will be used to improve future educational resources.
CONFIDENTIALITY
Only the investigators of this project will have access to your data. We will not share any of your
test results with anyone other than you. All information that is obtained during this study and
that can be used to identify you will remain confidential. Electronic data (including name, email,
and survey data) will be saved on a Western University network.
Written data will be securely stored in a locked cabinet in a secure office and personal
information will be saved on a password-protected computer in the research office at Elborn
College.
If the results are published, your name will not be used, and no information that discloses your
identity will be released or published without your specific consent to the disclosure. All data
will be kept for 5 years following the publication.
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Representatives of the Western University Health Sciences Research Ethics Board may contact
you or require access to your study related records to monitor the conduct of the study.
WILL I BE PAID TO PARTICIPATE IN THIS STUDY?
You will not be compensated for your participation in this study.
VOLUNTARY PARTICIPATION
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time. At the time of withdrawing from the study,
we will ask you to briefly provide your reasons for leaving the program. You do not have to
provide this feedback. In addition, you will have the decision to remove or allow your data to
continue to be used for research purposes. If you allow the researchers to use your data, that
data will remain with the research team.
QUESTIONS OR CONCERNS?
If you have questions about the research now or later, please feel free to contact the following:
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PARTICIPANT
CONSENT FORM
Title of the study: Evaluation of an Electrical Stimulation Therapy Education Program for the
Healing of Chronic Wounds
Primary Investigator: Pamela Houghton, PhD
Co-Investigators: Lyndsay Orr, MClSc; Paul Holyoke, PhD; Jillian Brooke, MClSc; Deena Lala, MSc

I have read the letter of information thoroughly. I have had the opportunity to ask
questions and all of my questions have been answered to my satisfaction. I agree to
participate in this study.
I prefer the researchers contact me through email.

________________________________
Participant Name (Print)
___________________________________________
_____________________________
Participant Signature

Date (MM/DD/YYYY)

If verbal consent is obtained in lieu of a signature, the person obtaining consent will initial here:
______
I confirm that I have explained the nature and purpose of this study to the participant named
above.
I have answered all questions.
________________________________
Person Obtaining Consent Name (Print)
_____________________________________________
_____________________________
Person Obtaining Consent
Copy of Study Results
I would like a copy of the study results:

Yes

No

Date (MM/DD/YYYY)
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Appendix 3: HSREB E-Stim Collaboration Project
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Appendix 4: Letter of Information and Consent- E-Stim Collaboration Project

PARTICIPANT
LETTER OF INFORMATION
Title of the study: Best Practice Implementation of Electrical Stimulation Therapy for Healing
Pressure Ulcers in Community Dwelling Individuals with Spinal Cord Injury
Primary Investigator: Pamela Houghton, PT, PhD
Co-Investigators: Dalton Wolfe, PhD; Deena Lala, MSc; Anna Kras-Dupuis, CNS; Patrick Potter,
MD; Eldon Loh, MD; Lyndsay Orr, PT, MClSc; Jacqueline Marsh, PhD; Katie Mairs, MSc; Anne
Shantz, RN.
Sponsors: Rick Hansen Institute
You are being invited to participate in a research study because you have a condition that limits
your mobility and/or requires you to use a wheelchair, and you are currently experiencing a
pressure ulcer. To decide whether or not you want to take part in this research study, you
should understand what is involved. This form will provide you detailed information about the
research study, which will also be discussed with you in person. Once you understand the study,
you will be asked to sign the form at the end of this information letter if you wish to participate.
PURPOSE OF THIS STUDY
Pressure ulcers are one of the most common secondary health complications among individuals
who have a condition that makes it difficult to walk. When skin breakdown occurs, it limits
people’s ability to participate in activities and increases the time they spend in bed, leading to
decreases in quality of life.
Many guidelines recommend the use of electrical stimulation therapy (EST) to promote the
closure of pressures ulcers. EST is a therapy used alongside standard wound care that mimics
the natural electrical current of the skin to stimulate the wound healing process. However, due
to limited knowledge and experience with EST, very few care providers in the community
provide this therapy.
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The purpose of this study is to determine whether we can successfully develop a program that
includes EST to improve the healing of pressure ulcers in individuals who have a condition that
makes it difficult to walk.
WHAT WILL BE ASKED OF YOU IF YOU PARTICIPATE
If you agree to participate in this study, you will participate in the following:
7. Pre-assessment: You will be provided a unique user name and password for a private
and secure website to complete the pre-assessment form related to your current and
past medical history.
8. A researcher and/or qualified clinician will arrange a visit in your home where he/she
will review the medical history form that you completed and perform a wound
assessment. We will take a photo of the wound and surrounding skin. This image will
assist in documenting changes in the wound status and lends important information
about how well the wound treatment is working. When taking these visual images of
the wound, a measuring ruler with your patient ID number and the date will be included
and the image will focus only on the area of the skin affected by the ulcer. Neither your
name nor any information that might reveal your identity will be contained in the
wound photograph. You may request at any time to have the photographs destroyed.
9. Assessment: You will undergo a comprehensive assessment by a team of health care
professionals such as a physician, registered nurse, physical therapist, occupational
therapists, social worker, and registered dietician. The assessment will include reviewing
any existing medical concerns and evaluating the wound size and appearance.
10. Care plan: A conference call will be set up between the team of health care
professionals, the study participant, all members of the participants care team in the
community (including family members, attendant services, and community care
providers), and any relevant researchers.. The care team will work with you to develop
a personal care plan that includes an EST treatment plan and schedule. EST is a therapy
used to deliver electrical current at low levels directly to the wound using specialized
electrodes and equipment, which will be provided to you at no cost. A trained person
will apply EST to the wound for 30-90 minutes at least 5 times a week. There is a
possibility that EST may not be suitable for you; in this case, you will still be provided a
customized pressure ulcer treatment plan that is based on Canadian best practice
guidelines.
11. Community follow-up: Based on the agreed care plan, you will be followed by members
of your community care team according to a pre-determined service plan available via
South West CCAC. This may include personal support workers, care attendants, family
members, nurses, physical and occupational therapists, dietician, and psychologist or
social workers supported by members of the research team.
12. Over the course of this study, you will be able to access educational resources and learn
as much as you want about pressure ulcer care and electrical stimulation therapy.
13. An evaluation of costs associated with your health care will occur by tracking your
equipment and health care services over the study period. This will be compared to
costs associated with your pressure ulcer care prior to study enrolment. This will involve
completing a cost diary and quality of life questionnaire (called EQ-5D-5L) at the
beginning of the study, monthly until the ulcer heals, or 1 year, or until study
completion, whichever comes first. We may also need to check your health records to
accurately estimate costs associated with your health care.
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14. You will be asked to complete a survey by phone or on the electronic platform to
describe your experiences with the program. You may elect to complete this survey and
questionnaire on hardcopy. If this is the case, the researchers will mail you a copy with a
stamped envelope included so you can mail the survey back to us.
If you feel uncomfortable using an electronic system to store your medical information, you can
choose to complete the pre-assessment forms and research surveys using hardcopy.
STUDY TECHNOLOGY
Multiple electronic systems are commonly used by health care professionals and community
agencies to store patient information and order medical tests. Unfortunately, not all of these
systems are linked or allow all users access. CHAYA is a web-based platform that allows for
patients and care providers at Parkwood Institute and in the community to share medical
information and communicate using a single system. CHAYA will also provide you access to
current resources that provide information and helpful hints about recommended best practices
in the area of pressure ulcer care. There is also information about why, when and how to apply
electrical stimulation therapy. For this study, you will have access to this educational site using
your existing home computer and Internet connection. If you do not have a computer, you will
be provided a tablet or laptop. CHAYA can be launched directly from an Internet browser and
you may login to your profile using a secure username and password.
All electronic personal health information (ePHI) such as name, address and email are encrypted
according to the Advanced Encryption Standard. CHAYA uses a secure socket layer (SSL), which
means that all the data sent through the system is encrypted to protect the privacy and
confidentiality of your information. Users who attempt to access data, for which they do not
have approved access, will be denied and their attempts will be logged and flagged.
Individuals who will have access to your ePHI include members of your care team including
providers at Parkwood Institute and in the community, and relevant members of the research
team. The feedback you provide in surveys and questionnaires will be shared with members of
the implementation committee, the investigators and their research team. However, this
information will not be linked to your personal information (i.e. name). You will be assigned a
unique ID when you login to the password protected site and answers to the surveys and
questions will be summarized and collated to reduce the chances that your comments will be
identified.
There will be many times in this study where the researchers will need to contact you. If you
prefer, we ask that you provide us your email address. Researchers will only email you to
schedule appointments and send reminders to complete study forms. Sensitive personal or
health information will be not be communicated through e-mail.
POSSIBLE RISKS
There are potential discomforts associated with wound care (e.g. pain associated with dressing
changes and debridement). However, these are standard clinical practices in wound care. There
are also risks associated with the use of EST, but they are minimal. Potential risks include skin
irritation (i.e. redness, and itchiness) under the electrodes, pain, infection or further breakdown
of the wound, and electric shock or surge if the EST device fails. You may also be asked to get a
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blood test to assess your nutrition. Possible side effects include pain and bruising at the site of
the needle hole. Bleeding and infection may also occur, but these complications are very rare.
There is also the potential to encounter technical difficulties when using CHAYA. In such case,
technical support will be available.
If you agree to e-mail communication, you need to understand the risks of using e-mail. The
security of e-mail is not guaranteed. Messages sent to, or from, researchers may be seen by
others using the Internet and e-mail can be accidently forwarded.
BENEFITS
There are possible benefits for participating in this study. You will receive a full work up of your
wound and a specific care plan by an interdisciplinary team who have advanced training in
wound care and EST treatment. You will also receive timely access to care providers in the
community, equipment and supplies (e.g. EST). During this study, you will have access to
resources that may contribute to your understanding of pressure ulcers and EST. In addition, the
information collected will help identify the barriers and facilitators of this program. This
information will be essential for the development of future programs that incorporate EST for
managing pressure ulcers, and improve access to health care services for individuals with SCI.
CONFIDENTIALITY
All information that is obtained during this study and that can be used to identify you will
remain confidential. Electronic data (including name, email, and survey data) stored in CHAYA
will be encrypted and stored on a secure server at Lawson. Your information will be sent to
Lawson directly from your home computer or tablet through a secure network. To ensure
privacy of your data, do not share your username and password with anyone that should not
have this information. The network is managed by an outside company who may occasionally
need to perform maintenance and troubleshoot problems with the online network; however,
your personal health information is completely encrypted and will not disclose any information
to them.
Written data will be securely stored in a locked cabinet in a secure office and personal
information will be saved on a password-protected computer in the research lab.
If the results are published, your name will not be used, and no information that discloses your
identity will be released or published without your specific consent to the disclosure.
Representatives of the Western University Health Sciences Research Ethics Board may contact
you or require access to your study related records to monitor the conduct of the study.
WILL I BE PAID TO PARTICIPATE IN THIS STUDY?
You will not be compensated for your participation in this study. However, any travel or other
expense you incur as a result of participating in this study will be reimbursed.
VOLUNTARY PARTICIPATION
Participation in this study is voluntary. You may refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your future care. If you
choose to not participate in this study, you will continue to receive usual care or your current
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care regimen. At the time of withdrawing from the study, we will ask you to briefly provide your
reasons for leaving the program. You do not have to provide this feedback. In addition, you will
have the decision to remove or allow your data to continue to be used for research purposes. If
you allow the researchers to use your data, that data will remain with the research team.
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PARTICIPANT
CONSENT FORM
Title of the study: Best Practice Implementation of Electrical Stimulation Therapy for Healing
Pressure Ulcers in Community Dwelling Individuals with Spinal Cord Injury
Primary Investigator: Pamela Houghton, PT, PhD
Co-Investigators: Dalton Wolfe, PhD; Deena Lala, MSc; Anna Kras-Dupuis, CNS; Patrick Potter,
MD; Eldon Loh, MD; ; Lyndsay Orr, PT, MClSc; Jacqueline Marsh, PhD; Katie Mairs, MSc; Anne
Shantz RN
Sponsors: Rick Hansen Institute
I have read the letter of information thoroughly. I have had the opportunity to ask
questions and all of my questions have been answered to my satisfaction. I agree to
participate in this study.
I agree to allow wound photographs to be obtained by my wound care team and used for
the purpose of documenting changes in my wound.
I prefer the researchers contact me through email to schedule appointments and send
reminders. My email address is: ____________________________________

________________________________
Participant Name (Print)
___________________________________________
_____________________________
Participant Signature

Date (MM/DD/YYYY)

If verbal consent is obtained in lieu of a signature, the person obtaining consent will initial here:
______
I confirm that I have explained the nature and purpose of this study to the participant named
above.
I have answered all questions.
________________________________
Person Obtaining Consent Name (Print)
_____________________________________________
_____________________________
Person Obtaining Consent

Date (MM/DD/YYYY)
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Appendix 5: Chapter 3 Unpublished Data
Forrest Plot Data, Pressure Ulcers
7 studies; 412 wounds / risk on healing: 139 (= 42,4%); 57,2% in the ES group & 21,3%
in the SWC group.

Study or Subgroup
Adunsky 2005
Asbjornsen 1990
Baker 1996
Griffin 1991
Houghton 2010
Kloth 1988
Wood 1993

Experimental
Control
Events Total Events Total Weight
5
35
3
28 15.5%
0
7
2
9
6.6%
68
125
24
67 23.7%
3
8
2
9 14.0%
11
16
4
18 19.3%
9
9
0
7
7.3%
43
43
1
31 13.7%

Risk Ratio
M-H, Random, 95% CI
1.33 [0.35, 5.10]
0.25 [0.01, 4.50]
1.52 [1.06, 2.17]
1.69 [0.37, 7.67]
3.09 [1.23, 7.80]
15.20 [1.03, 223.37]
21.09 [4.42, 100.64]

Total (95% CI)
243
169 100.0%
Total events
139
36
Heterogeneity: Tau² = 0.78; Chi² = 20.17, df = 6 (P = 0.003); I² = 70%
Test for overall effect: Z = 2.18 (P = 0.03)

Risk Ratio
M-H, Random, 95% CI

2.61 [1.10, 6.18]
0.01 0.1
1
10
100
Favours control Favours ES
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Appendix 6: Chapter 4 Costing Reference Table
Sex
ParticipantAge
47 Male
1001
42 Male
1002
69 Female
1003
65 Female
1004
45 Male
1005
35 Male
1006
70 Male
1007
63 Male
1008
36 Male
1009
41 Male
1010
81 Female
1013
53 Male
1014
41 Male
1016
63 Male
1017
87 Male
1018
47 Male
1019
69 Female
1020
61 Female
1024
69 Male
1026
78 Female
1027
74 Female
1028
48 Female
1029
Total
58.36364
Mean
15.46284
SD

? OSM

y

y
y

y
y
y

Level
L1
C6-7
L2-3
T5
C6-7
C4
T
T5-6
T4
T8
T4
T12
C5-6

y
C3
C5-6

T7

Site
SA
Injury SCI(years) Wound Duration(months)
1.4 coccyx
1
Incomplete L1 0.5
34 IT
8
Complete C6-7 18
0.9 IT
60
Complete L2-3 22
8.1 R buttock
Incomplete-spinal0.3stroke 4
0.8 IT
60
Complete C6-7 21
0.2 IT
48
6
Complete C4
1.7 IT
15
8
Incomplete-spinal stroke
11.6 heel
24
3
Cauda Equina
14.8 Coccyx
60
Complete T5-6 8
0.3 buttock
72
5
Complete T4
2.7 IT
36
Complete T8 28
3.8 IT
1
Complete T4 35
4.2 IT
39
Complete T12 16
13.9 IT
4
1
Complete
4.3 IT
10
Cauda Equina 17
7 Coccys
3
Complete C3-4 31
1.7 buttock
3
Buttock PrI, depression episode
1.1 R 5th toe
3
2
Complete
6.5 L BKA
3
L BKA
8 Shoulder
4
CVA
10.88 Coccyx
6
Parkinson's-Lewy Body
7.9 IT
2
Complete T7-8 27
466 145.78
248.8
13.82222 21.18182 6.626364
11.5233 24.22639 7.580844

CCAC
Stage
$ 1,984.95
DTI
$ 734.09
III
$ 1,925.83
IV
$ 1,984.95
III
$ 1,538.00
III
$ 1,077.00
IV
$ 2,249.00
IV
unstageable$ 1,275.24
$ 824.50
IV
$ 1,031.20
III
$ 1,984.95
IV
$ 1,984.95
III
$ 1,984.95
IV
$ 1,984.95
III
$ 1,984.95
IV
$ 4,842.37
IV
$ 1,984.95
III
$ 5,248.00
IV
$ 1,089.21
III
$ 1,984.95
IV
$ 1,984.95
IV
$ 1,984.95
III
$ 43,668.88
$ 1,984.95
$ 1,091.89

ER
$ 119.64
$ 119.64
$ $ $ 59.82
$ 59.82
$ $ 59.82
$ 59.82
$ 59.82
$ $ $ 59.82
$ 119.64
$ $ $ $ 59.82
$ $ 179.47
$ $ $ 957.14
$ 43.51
$ 52.81

Hosp
$
$ 1,545.90
$
$ 75,040.00
$
$ 770.34
$
$ 1,033.56
$
$
$
$
$
$ 25,540.67
$ 858.83
$ 9,035.98
$
$
$
$
$
$
$ 113,825.28
$ 5,173.88
$ 16,591.52

FP
$ 6.39
$ 6.39
$ 6.39
$ $ 12.78
$ 12.78
$ 12.78
$ 19.18
$ 19.18
$ 12.78
$ $ 25.57
$ 19.18
$ $ 6.39
$ $ 6.39
$ 12.78
$ 6.39
$ $ 19.18
$ 12.78
$ 217.32
$ 9.88
$ 7.57

Specialist Clinics
$ 26.17 $ $ 46.30 $ $ 39.06 $ $ - $ $ 12.89 $ 25.57
$ 39.63 $ 38.35
$ 6.39 $ $ 65.76 $ $ 39.63 $ 6.39
$ 19.91 $ $ 13.33 $ $ 107.70 $ 12.78
$ - $ $ - $ $ 8.33 $ $ - $ $ - $ $ 6.50 $ $ 45.15 $ $ 30.10 $ $ - $ $ - $ $ 506.84 $ 83.09
$ 23.04 $ 3.78
$ 27.24 $ 9.80

Tests
$ 10.78
$ 8.00
$ 2.67
$ $ 44.93
$ 5.34
$ 30.67
$ 4.17
$ 3.84
$ 8.00
$ $ 10.47
$ 31.91
$ $ 1.17
$ $ $ 24.50
$ $ 3.55
$ 1.17
$ 5.34
$ 196.48
$ 8.93
$ 12.51

Meds
$ 110.10
$ 106.44
$ 363.78
$ 642.60
$ 682.16
$ 1,384.84
$ 601.67
$ 102.60
$ 60.00
$ 78.90
$ 69.60
$ 33.17
$
$ 116.01
$ 27.90
$ 47.70
$ 239.70
$ 315.40
$ 39.61
$
$
$ 180.00
$ 5,202.18
$ 236.46
$ 332.20

pay lost
Costsprivate Wage
AdditionalHCP
- $
$ 1.33 $
- $
$ - $
- $
$ 0.67 $
- $
$ - $
- $
$ 3.33 $
$ 4.67 $ 3,040.00 $
- $
$ 8.33 $
- $
$ 2.00 $
- $
$ - $
- $
$ 0.67 $
- $
$ - $
- $
$ 1.67 $
- $
$ - $
- $
$ - $
- $
$ 1.33 $
- $
$ - $
- $
$ - $
$ - $ 2,000.00 $
- $
$ 1.33 $
- $
$ - $
$ - $ 3,040.00 $
- $ 521.60
$ - $
$ 25.33 $ 8,080.00 $ 521.60
$ 1.15 $ 367.27 $ 23.71
$ 2.03 $ 964.01 $

HC lost
$
$
$
$
$
$
$
$
$ 336.43
$ 3,129.60
$ 2,347.20
$
$ 1,564.80
$
$
$
$
$
$ 782.40
$
$
$
$ 8,160.43
$ 370.93
$ 857.76

Total
$ 2,259.36
$ 2,566.76
$ 2,338.39
$ 77,667.55
$ 2,379.48
$ 6,432.77
$ 2,908.85
$ 2,562.32
$ 1,349.78
$ 4,340.88
$ 4,415.08
$ 2,176.31
$ 3,660.66
$ 27,761.27
$ 2,888.91
$ 13,926.05
$ 2,231.04
$ 7,667.00
$ 1,964.09
$ 2,198.06
$ 5,045.29
$ 2,704.67
$ 181,444.57
$ 8,247.48
$ 16,549.35

Equipment
$ 10,150.00
$ 2,790.00
$ 43,900.00
$
$
$
$ 1,400.00
$ 44,860.00
$ 3,000.00
$ 3,100.00
$ 4,000.00
$ 300.00
$ 850.00
$
$ 400.00
$
$
$ 7,300.00
$
$ 800.00
$
8.00
$
$ 122,858.00
$ 5,584.45
$ 12,828.19
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Appendix 7: Curriculum Vitae

Lyndsay Orr, BScPT, MClSc (Wound Healing), PhD
LICENSURE
College of Physiotherapists of Ontario, Registration # 10768
EDUCATION
PhD(c), Health & Rehabilitation Sciences Graduate Program (enrolled September 2014)
University of Western Ontario
Masters of Clinical Science (Wound Healing), School of Physical Therapy,
University of Western Ontario, 2008
Bachelor of Science in Physical Therapy, Department of Physical Therapy
University of Western Ontario, 2000
EMPLOYMENT HISTORY
2018-Present
Clinical Lead

South West LHIN, South West Regional Wound Care Program

Jan-April 2017
Part Time Faculty

Western University, Faculty of Health Sciences, School of Physical
Therapy, London, ON

2014- 2018
Rehab First Inc., London, ON
Physiotherapist/Regional Manager
2006-2014
Cambridge Memorial Hospital, Cambridge, ON
Wound Care Resource/Physiotherapist
2001-2006
Physiotherapist

William Osler Health Centre, Brampton, ON

2000-2001
Physiotherapist

Credit Valley Hospital, Mississauga, ON

2000-2000
Physiotherapist

ProMotion Physiotherapy, London, ON

TEACHING ASSISTANTSHIP
September-December, 2018, Teaching Assistant, Western University, Faculty of Health
Sciences, School of Physical Therapy, Clinical Master’s in Wound Healing Program, PT 9670b:
Advanced Wound Treatment
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September-December, 2017, Teaching Assistant, Western University, Faculty of Health
Sciences, School of Physical Therapy, Clinical Master’s in Wound Healing Program, PT 9660a:
Wound Principles and Assessment
September-December, 2016, Teaching Assistant, Western University, Faculty of Health
Sciences, School of Physical Therapy, Clinical Master’s in Wound Healing Program, PT 9660a:
Wound Principles and Assessment
May-August, 2016, Teaching Assistant, Western University, Faculty of Health Sciences, School
of Physical Therapy, Clinical Master’s in Wound Healing Program, PT9620: Clinical Mentorship
September-December, 2015, Teaching Assistant, Western University, Faculty of Health
Sciences, School of Physical Therapy, Clinical Master’s in Wound Healing Program, PT9660a:
Wound Principles and Assessment
January-April, 2015, Teaching Assistant, Western University, Faculty of Health Sciences,
School of Physical Therapy, Clinical Master’s in Wound Healing Program, PT9670b: Advanced
Wound Treatment

PROFESSIONAL ACTIVITIES AND RESEARCH
2016-present Ontario Physiotherapy Association
Wound Care Management Course
Educator
2014-2017

SWLHIN Electrical Stimulation Collaboration Project
Clinical Coordinator, PhD Student

2013

Integrated Complex Chronic Wound Clinic: Waterloo Wellington LHIN Pilot
Project
Principal investigator

2009-2013

Evaluation of a hospital wide pressure ulcer prevention and treatment program
Yearly hospital wide prevalence and incidence studies conducted
Principal investigator

POSTER PRESENTATIONS SUBMITTED AND PEER-REVIEWED
Selected podium presentations
2018

Orr, L; Brooke, J; Colwell-Castles, S; Lacroix, H. Virtual Enterostomal Therapy (v-ET)
Nurse Consultation in Long Term Care (LTC) Homes: A Pilot Study, HSSO Conference:
2018, Toronto, ON

2017

Orr, L; Brooke, J; Holyoke, P; Lala, D; Houghton, P. Evaluation of an Electrical
Stimulation Therapy Education Program for the Healing of Chronic Wounds: Preliminary
Results, Wounds Canada Conference: 2017, Mississauga, ON
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2016

Lala, D; Orr, L; Holyoke, P; Houghton, PE; Kras-Dupruis, A; Wolfe, D. Implementation of
electrical stimulation therapy for treating pressure ulcers in community dwelling
individuals with limited mobility: preliminary findings. Canadian Association of Wound
Care Conference: 2016, Niagara Falls, ON

2016 Orr, L; Klement, K; McCrossin,L; O’Sullivan-Drombolis,D; Houghton,P. Exercise
intervention for the treatment of calf muscle impairment in individuals with chronic
venous insufficiency: a systematic review and meta-analysis. HRS 9th Annual Graduate
Research Conference: 2015, London, ON
2015

Orr, L; Klement, K; McCrossin,L; O’Sullivan-Drombolis,D; Houghton,P. Exercise
intervention for the treatment of calf muscle impairment in individuals with chronic
venous insufficiency: a systematic review and meta-analysis. Canadian Association of
Wound Care Conference: 2015, Toronto, ON

2015

Orr, L. Physiotherapy interventions for offloading diabetic foot ulcers: A narrative
review. HRS 8th Annual Graduate Research Conference: 2015, London, ON

2015

Orr, L. & O’Sullivan-Drombolis, D. Physiotherapists and the impairment based treatment
of chronic wounds. HRS 8th Annual Graduate Research Conference: 2015, London, ON

2014

Orr, L & Winberg, V. Ontario Woundcare Interest Group, Fewer Wounds Faster Healing.
Ontario Physiotherapy Association: InterACTION 2014, Mississauga, ON Co-presented
with V. Winberg.

2014

Houghton, PE; Nussbaum, E; Orr, L. Promoting Physical Therapist Involvement in
Wound Care, Ontario Physiotherapy Association: InterACTION 2014, Mississauga, ON
Co-presented with Drs Houghton and Nussbaum

2013

Teague, L; Hanna-Bull, D; Laforet, K; Orr, L; Thompson R; Winberg, V. Evolution of a
Wound Health Political Action Group: The Ontario Woundcare Interest Group,
Canadian Association of Wound Care, Vancouver, BC Co-presented with D. Hanna-Bull,
K. Laforet and V. Winberg.

Poster
2018

Orr, L; Brooke, J; Colwell-Castles, S. Virtual Enterostomal Therapy (v-ET) Nurse
Consultation in Long Term Care Homes: A Pilot Study Involving Local Integrated Health
Network and Nursing Service Provider. CAET Annual National Conference: Victoria BC.

2017

Orr, L; Brooke, J; Holyoke,P; Lala, D; Houghton, P. Evaluation of and Electrical
Stimulation Therapy Education Program for the Healing of Chronic Wounds: Preliminary
Results. National Spinal Cord Injury Conference: Niagara Falls, ON

2017

Orr, L; Brooke, J; Holyoke,P; Lala, D; Houghton, P. Evaluation of and Electrical
Stimulation Therapy Education Program for the Healing of Chronic Wounds: Preliminary
Results. Ontario Spinal Cord Injury Research Network Meeting: Toronto, ON

2014

Orr, L & O’Sullivan-Drombolis, D. Physiotherapy Interventions for Offloading of Diabetic
Foot Ulcers, Canadian Association of Wound Care conference, Toronto, ON
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2014

O’Sullivan-Drombolis, D & Orr, L. Physiotherapists and the Impairment Based
Treatment of Chronic Wounds, Canadian Association of Wound Care conference,
Toronto, ON

2012

Orr, L & O’Sullivan-Drombolis, D. Electrical Stimulation Therapy versus Negative
Pressure Wound Therapy: A comparison of adjunctive therapies utilized in home care
for chronic wound healing, Canadian Association of Wound Care conference, London,
ON

2012

O’Sullivan-Drombolis, D; Orr, L; Houghton, PE; Nussbaum, E. Wound Care and the
Amendments to the Physiotherapists Scope of Practice in Ontario, Canadian Association
of Wound Care conference, London, ON

2010

Orr, L & O’Sullivan-Drombolis, D. The Underutilization of Physical Therapists and
Biophysical Agents in Wound Healing, Canadian Association of Wound Care
conference, Calgary, AB

2008

Hon J; Lagden K; McLaren AM; O’Sullivan D; Orr L; Houghton P; Woodbury G. A
prospective, multicenter Study to Validate Use of the Pressure Ulcer Scale for Healing
(PUSH) in patients with Diabetic, Venous and Pressure Ulcers, World Union of Wound
Healing Societies, Toronto, ON

PUBLICATIONS
Orr, L; Klement, K; McCrossin,L; O’Sullivan-Drombolis,D; Houghton,P. Exercise intervention for
the treatment of calf muscle impairment in individuals with chronic venous insufficiency: a
systematic review and meta-analysis. 2017; Aug 63(8): 30-43.
Orr, L. Offloading of Diabetic Foot Ulcers: The role of the physiotherapist as part of a
multidisciplinary team. Diabetic Foot Canada. 2015; 3: 18-22.
Registered Nurses' Association of Ontario (2011). Risk Assessment and Prevention of
Pressure Ulcers Guideline Supplement. Toronto, Canada: Registered Nurses' Association of
Ontario. 1 of 14 authors.
O’Sullivan, D & Orr, L. Underutilization of Physical Therapists and Biophysical Agents in Wound
Healing. Wound Care Canada. 2011;9(3):10-16.
Hon J; Lagden K; McLaren AM; O’Sullivan D; Orr L; Houghton P; Woodbury G. A prospective,
multicenter Study to Validate Use of the Pressure Ulcer Scale for Healing (PUSH) in patients
with Diabetic, Venous and Pressure Ulcers. OWM. 2010;56(2):26-36.
HONORS AND AWARDS
2017 Ontario Graduate Scholarship
2016 HRS Graduate Conference Travel Award, Western University, Faculty of Health Sciences.
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2016 Siskinds Studentship in Spinal Cord Injury Endowment Fund Award, Parkwood Institute
Research Program: Awarded from the St. Joseph’s Health Care Foundation.
2015 HRS Graduate Conference Travel Award, Western University, Faculty of Health Sciences.
2004 Professional Practice Clinical Practice Award of Excellence, William Osler Health Centre,
Brampton, ON: Awarded to one clinician who is recognized for their excellence for clinical
practice. William Osler Health Centre organization which provided programs and services to
over 900,000 residents with a health care team of more than 900 physicians, 4,300 staff and
1,00 volunteers.

